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ABSTRACT 
Three hypotheses were tested in present studies: 1. that a threshold 
dose of fumonisin 3^ (FB-J hepatotoxicity and tumor promotion may be below 
50 ppm in a short-term diethylnitrosamine (DEN) initiation/FB-. promotion 
model; 2. that modifying FBt with fructose may reduce or prevent 
hepatotoxicity and tumor promotion in rats; 3. that isoflavones at 1 
mmol/kg diet may at least partly inhibit FBT-promoted rat 
hepatocarcinogenesis. 
A short-term threshold dose of FB: hepatotoxicity and 
hepatocarcinogenicity was determined in rats initiated with DEN and 
promoted with 18, 35 and 70 ^unol FBi/kg diet (12.5, 25 and 50 ppm FBi, 
respectively). Increases in plasma alanine aminotransferase (ALT) activity 
and plasma total cholesterol (TC) concentration were found in animals fed 
35 and 70 (imol FB>/kg diet, and greater hepatic prostaglandin (FG) 
production in the group fed 70 (imol FBi/kg diet. Placental glutathione S-
transferase (PGST)- and gamma-glutamyltransferase (GOT)-positive altered 
hepatic foci (.AHF) developed with feeding 35 and 70 (imol FBi/kg diet. The 
short-term threshold of FB, hepatotoxicity and hepatocarcinogenicity, 
therefore, was probably >18 (imol but <35 (imol FBi/kg diet. 
Fumonisin B-_ reacted with fructose (FB,-fructose) was evaluated for 
deto.>:ification in DEN-initiated rats. Feeding 70 ^mol FB-/kg diet increased 
plasma .°iLT activity, plasma TC concentration, and hepatic PG synthesis. 
Only FB;-fed rats had PGST- and GGT-positive AHF. Liver-associated natural 
killer (NK) cell activity was significantly decreased in the FB:-fed rats 
and increased in the group fed 70 [imol FBi.-fructose/kg diet. Therefore, 
reacting FB-, with fructose eliminated tumor promotion by FB, while 
stimulating the NK cell activity. 
To evaluate whether isoflavones suppress FBi-promoted 
hepatocarcincgenesis, DEN-initiated rats were fed 1 mmol isoflavones/kg 
diet with 18, 35 and 70 nmol FBi/kg diet. Development of PGST- and GGT-
positive AHF and increases in plasma ALT activity, plasma TC concentrati 
and hepatic PG production were found with feeding 70 jimol FB-Vkg diet wit 
or without isoflavones. Significant increases in plasma ALT activity, 
plasma TC, and developm.ent of PGST- and GGT-positive .AHF were shown wit.h 
feeding 35 (imol FB-./kg diet, but these effects were diminished by 
isoflavones. Therefore, isoflavones suppressed rat hepatocarcinogenesis 
promoted by 35 (Xmol but not 70 |xmol FB,/kg diet. 
GENERAL INTRODUCTION 
Resui~s frc.T. ~hree studies are present:ed in this disserrarion. 
F'-imcr-isir. 3; hepatczoxiciry and hepatccarrincger.esis in rats are 
investigated in. Study . Two different apcroacnes to FB: detoxif icat:Lcn are 
reported in Study 2 and Study 3. 
Study 1. Threshold Dose for Short-Term Cancer-Promotion by Dietary 
Fumonisin-Bi in Diethylnitrosamine-Initiated Rat Hepatocarcinogenesis 
Fumonisins are recently discovered "vcotcxins produced cy the 
predominant corn fungi Fl'Ss rijin anc crcliferazi::n. 
"u-Tionisin 3; iFB-., , a .Tiajcr ~eincer zz tne fu-ticn-sin family, caused equine 
leui-'-cencephalorrialatia '.Kellerman et al., 1390; Wilson et al., 15921 and 
pcrcine pulmonary edema ^Harrison et al., 1990', and was nepatctoxic and 
nepatocarcinogenit in rats 'Gelderblcm. et al., 153S and 1991; . The 
occurrence tf FB-. _n F. :r.or.lllfcr~e-czr.zariLr.azez corn was implicated in a 
relatively high rate cf human esophageal cancer in southern Africa 'Marasas 
et al., 1989; Sydenham et al., 199G). 
Several bicmarkers have bee.n usee to stucy F3; hepatotcxicity and 
hepatocarci.noge.nicity. Fum.cnisin 5-.-prtmcted rat nepatccarcincge.nesis was 
readily quantifiec by measuring place.ntal glutat.hione S-tra.nsferase {PGSTi-
positive altered hepatic foci ;.A.KF; Lebepe-Hatur et al., 1995; and gamma-
glutarayltransf erase '.GQT;-positive foci ;Geiderblotn et al., 1985] . Because 
cf the early occurrence cf PGST induction, v-yhic.h was evident withi.n 4 8 h in 
single hepatocytes after diethyl.nitrosa.r.i.ne i.nitiaticn (Moore et al. , 
19S7;, and because of the persistence cf bot.h ?GS7 and GGT during 
nepatocarcinogenesIS ;.Hendrich et al., 1937) , t.hese two encvuies can serve 
as sensitive bicm.arkers of early stages cf hecatccarci.nogenesis. Our 
previous study s.ncwed tnat coth rGST— and GGT — cositive A'AT were detected 
after -4 wee.ks in rats fed cl com crucel-.- our-f--d -nd h'ch'v 
cp.olesteroi (TC) level and alanine aminotransferase (ALT) activity have 
been associated with fumonisin hepatotoxicity and hepatocarcinogenicity. 
Fusarium proliferacum strain 5991-fermented corn providing 50 ppm FB. to 
DEN-initiated rats significantly increased plasma TC and ALT while causing 
hepatocellular adenomas (Hendrich et al., 1993). Similar results were 
obtained using highly purified FBi, and additionally, greater hepatic 
prostaglandin production was related to FB.-promoted hepatocarcinogenesis 
in rats (Lu et al., 1997). 
Fumonisin B, has recently been listed as a class 2B carcinogen 
(International AqencY Research on Cancer, 1993) . Development of 
appropriate animal models of carcinogenesis is critical to understanding 
the probable FB; carcinogenicity in humans. Because nitrosamines often 
contaminate .human diets (National .Academy of Sciences, 1981) , and FB; is 
almost always found in corn-based human foods, a 2-stage rodent model 
combining DEN to initiate and FB; to promote carcinogenesis may approach tc 
some extent the reality of .human carcinogenesis (Hendrich et al., 1997). 
One advantage of utilizing this model is that the cancer promoting 
potential of FB; can be readily quantified by PGST- and GGT-positive .AHF. 
Our DEN initiation/FB; promotion model, i.e. initiation of rats with DEN 
(15 mg/kg body weight) followed by 50 ppm FB; promotion for 4 weeks, can 
induce rat hepatocarcinogenesis rapidly, requires relatively small amou.nts 
of FB;, and may mimic the natural e.nvironment where humans are exposed to a 
combination of chemical carcinogens. 
Although FB; was non-mutagenic in the Salmonella mutagenicity assay 
(Gelderblom and Snyman, 1991) and lacked genotoxicity based on unscheduled 
DNA synthesis assay in primary rat hepatocytes (Norred et al., 1992), it 
seemed to be a complete carcinogen either at 50 ppm long-term (18-24 
months) or at 250 ppm. short-term (3 weeks) (Gelderblom et al., 1991 and 
1994). As a potent promoter in the DEN initiation/FB; promotion .model, 
fumonisin B; was effective to promote hepatocarcinogenesis at a dietary 
level of 50 ppm in 4-wee!c studies (Hendrich ec ai., 1993; Lu et al., 1997). 
It was unknown, however, whether 50 ppm was the cancer-promoting threshold 
dose of FB; short-term. This exposure level to FBi may still be an order of 
magnitude higher than the natural occurrence of FB:. in corn-based human 
foods and ani.mal feeds, which commonly contained 0.2-3 ppm FB: (Hopmans and 
Murphy, 1993; Murphy et al., 1993; Sydenham et al., 1991). 
In Study 1 using the short-term DEN initiation/FB-. promotion model, 
it was hypothesized that FB; would still e.xert hepatotoxic and cancer-
promoting effects at dietary concentrations lower than 50 ppm. The dietary 
levels of FBi were lowered to 25 and 12.5 ppm to approac.h more closely the 
natural occurrence of FB-., to establish dose-response effects of FB-. on 
hepatotoxicity and hepatocarcinogenesis in rats, and to ascertain a shorr-
term cancer-promoting threshold for FB;. 
Study 2. Reaction with Fructose Detoxifies Pumonisin Bi While Stimulating 
Liver-Associated Natural Killer Cell Activity in Rats 
It was hypothesized in this study that modifying FB; with fructose 
would reduce or prevent FB; hepatoto.xicity and promotion of 
hepatocarcinogenesis in rats. Efforts were devoted to detoxifyi.ng FB; in 
several ways. Thermostability of FB. proved to be great, because nearly 85s 
of FB; was recovered after different heat treatments: 75°C for 135 min., 
100°C for 45 min., and 125°C for 5 min. (Dupuy et al., 1993). Treatment of 
fumonisin-contaminated corn with 21 ammonia for 4 days, a process that 
deto.xified aflatoxin B;, led to slight reduction in the concentration of 
FB; without decreasing the toxicity in rats (Norred et al., 1991). 
Hydrolyzed FB;, which was produced by boiling F. proiiferacum-contaminated 
corn in 1.2% calcium hydroxide solution for 1 h, was similar in toxicity to 
FB; when the nutritional status of rats was adequate (Hendrich et al., 
1993). In vitro toxicity studies on several analogs of FB; showed that the 
analogs containing FB;'s amine group and the tricarballylic side chains 
were more to.xic than FB-., whereas the analog containing only the 
4 
tricarballylic side chains was aon coxic (Kraus ec al., 1992). The N-acecyl 
derivative of FB; at 1 mM was not toxic in primary rat hepatocytes. In 
addition, rats fed N-acetyl-FBi at about 1.3 mmol/kg diet did not exhibit 
hepatic neoplastic nodules or increased hepatic GGT activity (Geiderblom et 
al., 1993). Therefore, FBi's amine group is likely to be critical for its 
toxicity. The N-acetyl-FB. may be produced during the isolation and 
purification of FBi from corn cultures of F. moniliforme. Study 2 employed 
a dedicated and more practical method to block FB-/s amine group by 
reacting the amine group with reducing sugars such as fructose in a 
Maillard reaction. The study was designed to evaluate whether reaction with 
fructose would detoxify FB-,. 
Study 3. Suppression of F^imonlsin Bi-Promot:ed Rat Hepatocarciziogenesis by 
Genistein and Daidzein Depends upon Fvunonisin Bx Dose 
Greater soybean consumption was associated with lower risk of certai.n 
horm.one-dependent cancers in Asian countries (reviewed by Adlercreutz et 
al., 1995). The protective role that soybeans may play against development 
of human cancers was demonstrated in animals. Rats fed a diet containing 
50% soybeans had a significantly lower incidence of X-ray irradiation-
induced adenocarcinomas and fibroadenomas in mammary glands compared with 
chow-fed and casein-fed rats (Troll et al., 1980). Feeding soy protein 
isolate to rats decreased tumor incidence by 50% and increased latency in 
an N-methyl-N-nitrosourea (MMU) model of mammary cancer (Hawrylewicz et 
al., 1991). Feeding both autoclaved soybean powder and soy protein isolate 
to rats reduced the number of mammary tumors induced by carcinogens NMU and 
7, 12-dimethylbenz[a]anthracene (DMBA) (Barnes et al., 1990). 
Isoflavones, mainly genistein, daidzein and their glucoside 
conjugates, are abundant in soybean foods (0.2-1.5 mg/g) (Wang and Murphy, 
1994). Soybean isoflavones may contribute in large part to the 
anticarcinogenic effects associated with soybean consumption. Feeding 
genistein to rat pups in the neonatal period delayed the appearance and 
reduced incidence of breast cancer after the rats were administered DMBA at 
50 days of age (Laiaartiniere et al., 1995). In DEN-initiated rats, soybean 
isoflavone extract providing i mitiol or 2 mmol isoflavones/kg diet 
suppressed phenobarbitai-promoted hepatocarcinogenesis after 3 months of 
feeding, as evidenced by the decreased the development of GGT- and PGST-
positive AHF (Lee et al., 1995). 
Most animal studies on the proposed anticarcinogenic ability of 
isoflavones utilized rodent mammary carcinogenesis models. Because FB-. is 
almost always found in appreciable amounts in corn-based human foods and 
ani.mal feeds, and it is potentially a human carcinogen, investigating 
whether isoflavones exert anticancer effect in a rodent .model of FB; 
hepatocarcinogenesis is warranted. Using a 2-stage hepatocarcinogenesis 
model, i.e. DEN (15 mg/l<g body weight) initiation of rats followed by FB; 
(70 ^imol/kg diet) promotion for 4 weeks, our previous study demonstrated 
Chat feeding isoflavone extract providing 1 mmol isoflavones/kg diet 
suppressed FB;-promoted rat hepatocarcinogenesis, as reflected in reduced 
hepatic prostaglandin F;^ production and plasma IkLT activity, and 
suppressed development of PGST-positive AHF (Hendrich et al., 1997). 
Study 3 was designed to determine whether our previous finding could 
be e.xtended from soy isoflavone extract to isoflavones with the same 
carcinogenesis model. Fumonisin B; concentrations of 18, 35 pmol in 
addition to 70 ^imol FBi/kg diet were chosen to appro.ximate the natural 
occurrence of FB- in corn-based human foods and animal feeds. Because 
isoflavone extract was able to suppress FBi-promoted hepatocarcinogenesis, 
and isoflavones were considered to be responsible in large part for the 
effect, it was hypothesized that dietary isoflavones may at least partly 
inhibit rat hepatocarcinogenesis promoted by FB;. 
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LITERATURE REVIEW 
Fumonisins are recently discovered mycotoxins produced by the 
predominant corn fungi Fusarium moniliforme and Fusarium proliferacum. 
Fumonisin B-, (FB-J, a major member of the fumonisin family, caused equine 
leukoencephalomalacia (ELEM! (Kellerman et al., 1990; Wilson et al., 1992) 
and porcine pulmonary edema (PPE) {Harrison et al., 1990), and was 
hepatotoxic and hepatocarcinogenic in rats {Gelderblom et al., 1988 and 
1991). The occurrence of F. moniliforma containing FBi was implicated in a 
relatively high rate of human esophageal cancer in southern .^ifrica (Marasas 
et al., 1988; Sydenham et al., 1990). 
Discovery of E\imonisins 
The discovery of fumonisins began with observations that F. 
moniliforme was involved in widespread field outbreaks of animal diseases 
occurring in the United States in the early 1900s. The development of these 
diseases in cattle, horses, pigs and chickens was associated with ingestion 
of moldy corn. Fusarium moniliforme >ias the fungus most commonly found in 
moldy corn and was implicated as the cause of the disease "moldy corn 
toxicosis" (Peters, 1904). In the 198Gs, the occurrence of F. moniliforme 
in corn was correlated with high rates of human esophageal cancer in 
Transkei, southern Africa a.nd in China, where corn is a major dietary 
staple (Marasas et al., 1981; Yang, 1980). When culture material of several 
isolated strains of F. moniliforme from the contaminated corn was fed to 
animals, cirrhosis and nodular hyperplasia of the liver and 
intraventricular cardiac thrombosis were found in rats, 
leukoencephalomalacia and toxic hepatosis in horses, pulmonary edema in 
pigs, nephrosis and hepatosis in sheep, and acute congestive heart failure 
in baboons (Kriek et al., 1981). Strain MRC 826 of F. moniliforme grown on 
autoclaved corn was hepatocarcinogenic to rats (Marasas ec al., 1984). 
Corn-based animal feeds naturally contaminated with F. moniliforme and 
associated with outbreaks of ELEM caused hepatic nodules in F344 rats after 
123 days of feeding. Histological examination revealed multiple hepatic 
neoplastic nodules, large areas of adenofibrosis and cholangiocarcinomas 
(Wilson et al., 1985). 
The discovery of fumonisins results from the dedicated search for the 
etiology of the high incidence of human esophageal cancer in Transkei of 
southern Africa. Gelderblom et al. (1986) utilized a cancer 
initiation/promotion bioassay, which was based on a chemical carcinogenesis 
model established by Pitct et al. (1978), to evaluate the cancer promoting 
ability of strain MRC 826 of F. moniliforine isolated from Transkeian corn. 
Hepatectomized rats were initiated with diethylnitrosamine (DEN, 30 mg/kg 
body weight) and then fed a diet containing culture material of MRC 826 at 
a level of 2% for 14 weeks. Gamma-glutamyltransferase (GGT)-positive 
altered hepatic foci (AHF) , which are preneoplastic, developed, indicating 
-he cancer promoting activity of strain MRC 826. This carcinogenicity was 
also shown in non-hepatectomized rats when the culture material of strain 
MRC 826 (5% of the diet) was fed for 14 weeks following initiation with DEN 
(200 mg/kg body weight) (Gelderblom et al., 1986). A similar bioassay with 
shorter promotion was later used to screen MRC 826 and 10 other strains of 
F. moniliforme for their cancer promoting ability in rat liver. One week 
after initiation with DEN (200 mg/kg body weight), a diet containing 
culture material (5%) of each strain was fed to non-hepatectomized rats for 
4 weeks. Based on the appearance of GGT-positive AHF, three out of 10 
tested strains plus MRC 826 exhibited cancer promoting ability (Gelderblom 
et al., 1988a). 
Compared with cancer initiation/promotion treatment, strain MRC 826 
alone without DEN initiation caused far less pronounced development of GGT-
positive -AHF in rat liver (Gelderblom et al., 1986) . Fusarium monili forma 
corn culture fed to rats before a single dose of DEN caused an increase in 
the number of placental glutathione S-transferase (FGST}-positive AHF in 
rat liver, another early indicator of hepatocarcinogenesis (Lebepe and 
Hendrich, 1991). These results suggest that in addition to cancer promoting 
activity, F. moniliforma has cancer initiating or co-initiating activity as 
we 11. 
The short-term cancer initiation/promotion bioassay was further used 
as a monitoring system to isolate the carcinogenic fumonisins from the 
culture material of F. monili forme strain MRC 826. The corn culture was 
extracted with ethyl acetate and methanol;water (3:1). The cancer promoting 
activity was recovered in the methanol:water extract and remained in t.he 
aqueous phase after partitioning with chloroform. This fraction was then 
run through Amberlite XAD-2 column, a silica gel column, and a C., reverse 
phase column. Two compounds in the fraction were isolated and were named 
fumcnisin 3-. (FB;) and fumonisin B; (FB;) . After being fed to rats for 4 
weeks at a level of 1000 ppm (0.1») in the diet, fumonisin B- induced 
hepatocarcinogenesis, as seen in the development of GGT-positive AHF 
(Gelderblom et al., 1988b). 
In another experiment, a diet containing 50 ppm of isolated FB. was 
fed to 25 rats for 18-26 months. Ten of 15 FB,-treated rats that died cr 
were killed after 18 months of treatment developed primary hepatocellular 
carcinoma (Gelderblom et al., 1991). Taken together, fumonisin B. is a 
complete carcinogen to rats. Whether FB. causes human esophageal cancer 
needs further investigation. 
Fumonisins are a family of structurally related mycotoxins. In 
addition to FB. and FB;, four other fumonisins-B,, B^, A. and A-, have been 
characterized. Fumonisin B. is a diester of 2-amino-12,16-dimethyl-
3,5,10,14,15-pentahydroxyicosane with both C-14 and C-15 hydroxyl groups 
esterified with propane-1,2,3-tricarboxylic acids. Fumonisins B, and B, 
lack the hydroxyl groups at C-IG and C-5, respectively, whereas both 
hydroxyl groups are replaced by hydrogens on fumonisin 3^. Fumonisins A, 
and A„ are N-acetates of fumonisins B. and B., respectively. Most of the 
naturally produced fumonisins in corn cultures of F. moniliforme strain MRC 
826 are fumonisins B., B, and B, (Bezuidenhout et al., 1988; Cawood et al., 
1991). 
Fusarium moniliforme is not the only fumonisins-producing Fusarium 
species. Ross et al. (1991) reported production of fumonisins by another 
Fusarium species, Fusarium proliferatum. Fusarium moniliforme and F. 
proliferacum were isolated from 9 feed samples, seven of which were 
associated with equine leukoencephalomalacia or porcine pulmonary edema. 
O 
Production of FB. and FB, in corn cultures, incubated for 2 weeks at 27 c 
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followed by two weeks at 15 C, was basically the same for the two related 
species. Testing the ability of F. proliferacum for FB- production. Nelson 
et al. (1992) found chat 17 of 31 tested strains of F. proliferacum 
produced >500 ppm of FB.. Those strains producing >500 ppm FB; were 
considered as high producers. 
Fumonisin Levels in Com-Based Human Foods and Animal Feeds 
Murphy et al. (1993) conducted a survey on fumonisin B., 3. and B, 
contents of corn from the 1988 to 1991 crop years and corn screenings from 
198 9. A total of 175 whole corn samples harvested from those years in Iowa 
and 160 corn screening samples were randomly selected. Fumonisin B., B. and 
B, levels in corn ranged from 0-37.9 ppm, 0-12.3 ppm and 0-4.0 ppm, 
respectively. Average FB. concentrations were similar (2.5-3.3 ppm) for the 
4 crop years surveyed. Corn screenings contained about 10 times higher 
fumonisin levels than whole corn (Murphy et al., 1993). Feeds associated 
with animal health problems were assayed for FB. contents by Ross et al. 
(1991). Fumonisin B, concentrations ranging from <1 ppm to 126 ppm and from 
<1 ppm to 330 ppm were detected in feeds associated with ELEM and ?PE, 
respectively. The FB, concentrations in feeds not associated with ELEM or 
PPE were always <9 ppm, and 94% of the samples contained <6 ppm (Ross et 
al., 1991). In samples of poor quality corn associated with human 
esophageal cancer, fumonisin Bi concentrations were generally higher than 
in good quality homegrown corn. Up to 140 ppm FB: were detected in 
•laturally contaminated corn from some areas with high incidence of human 
esophageal cancer, whereas average FB. concentrations of 0.4 to 1.8 ppm 
were found in good quality corn (Rheeder et al., 1992). Several surveys to 
determine the occurrence of FB-. in corn-based human foods and animal feeds 
showed that FB-. levels commonly ranged from 0.2 to 3 ppm (Hopmans and 
Murphy, 1993; Murphy et al., 1993; Sydenham et al., 1991). .i^lthough human 
e.xposure to fumonisins was clearly indicated, further studies are needed to 
determine the potential risk associated with this exposure. 
Fumonisln Toxicity and Carcinogenicity 
Equine leukoencephalomalacia is a neurotoxic disease that affects 
horses, donkeys and mules. It is characterized by liquifactive necrosis of 
the white matter i.n one or both cerebral hemispheres (Marasas et al., 
1983). Typical clinical signs of ELEM include uncoordination, aimless 
walking, blindness and head pressing (Wilson et al., 1990). The causative 
agent of ELEM was found by Wilson and Maronpot (1971) when they isolated F. 
moniliforme as the predominant contaminant of moldy corn that was 
associated with many cases of ELEM, and when they reproduced ELEM in 2 
donkeys by feeding F. moniliforme corn culture material. Shortly after 
isolated FBi had been available, a horse was injected intravenously 7 times 
in 9 days with FBi at 0.125 mg/kg body weight. Clinical signs of ELEM 
appeared on day 8, and brain edema and focal necrosis in the medulla 
oblongata were found on day 10 (Marasas et al., 1988). Reproduction of ELEM 
in 2 horses by oral dosing of FB: was reported later. Typical lesions of 
ELEM were present in the brains of both horses (Kellerman et al., 1990). 
Porcine pulmonary edema was associaced with occurrence of F. 
moniliforme when 2 pigs developed the disease following feeding on bulk 
culture material of corn contaminated with F. moniliforme (Kriek et al., 
1981). In another study, pulmonary edema and hydrothorax were found in 2 
pigs and F. moniliforme was recovered from the cultured corn screenings. 
The concentration of FB. ranged from 105 ppm to 155 ppm in the feed samples 
associated with PPE (Harrison et al., 1990). Additional test was run on a 
pig with FB.. The animal received daily intravenous injection of 0.4 mg 
FB./kg body weight and died on day 5. Necropsy showed the pig developed PPE 
(Harrison et al., 1990). 
Fusarium moniliforme contamination of feed has been implicated in 
diseases of poultry (Engelhardt et al., 1989). Ducklings fed rations 
containing 100, 200 and 400 ppm FB. had decreased weight gain and increased 
weights of liver, heart, kidney and pancreas in a dose-dependent fashion. 
Mild to moderate hepatocellular hyperplasia was found in all ducklings fed 
FB- (Bermudez et al., 1995). Because the levels of fumonisins used in 
poultry studies were relatively high (75-644 ppm), poultry may be more 
resistant to the toxic effects of FB; than other animals. 
Fum.onisin B. is fetotoxic to some animals. Lebepe-Mazur et al. (1995) 
reported that rat fetuses from mothers fed with 60 mg FB./kg body weight on 
days 8-12 of gestation had significantly lower body weight by 21% and 
impaired bone development. Developmental toxicity of a water extract of F. 
Moniliforme culture material was also shown in hamsters (Floss et al., 
1994). Up to 12 mg FB./kg body weight was administered by gavage to the 
pregnant hamsters from day 8 to day 12 of gestation. With increased FB. 
doses, more fetuses were lost per litter. At 12 mg FB./kg, all hamster 
fetuses were dead. 
The liver is a target organ of fumonisin toxicity and carcinogenicity 
in rats. Culture material of strain MRC 826 of F. moniliforme fed to rats 
ac 3% dietary level caused cirrhosis, nodular hyperplasia and bile-duct 
proliferation in the liver, and was lethal to all rats. The culture 
material was also hepatocarcinogenic, causing hepatocellular carcinoma and 
ductuiar carcinoma (Marasas et al., 1984). Unlike most mycoto.xins, 
fumonisins are water soluble. This feature was helpful to identify the 
causative hepatotoxins produced by F. moniliforma strain MRC 326. Diets 
containing water extract or chloroform:methanol (1:1) extract of MRC 826 
culture material, or remaining culture material after the extraction, were 
fed to rats for 4 weeks. The animals fed water culture material e.xtract or 
the remaining culture material after chloroform:methanol extraction had 
microscopic liver lesions, and elevated alanine aminotransferase, aspartate 
ami.iotransferase and alkaline phosphatase activities. Fumonisins Bi and B2 
were detected in the water e.xtract but not chloroform:methanol extract, and 
were present in the toxic diets in concentrations of 93-139 and 82-147 ppm, 
respectively (Voss et al., 1990). In another e.xperiment, a diet containing 
50 ppm of isolated FBt was fed to 25 rats for 18-26 months. A group of 
control rats received no FB-. Ten of 15 FBr-treated rats that died or were 
killed after 18 months of treatment developed primary hepatocellular 
carcinoma (Gelderblom et al., 1991). Hepatotoxicity was evident after 6 
months and progressed in severity with time. These results suggest that 
fumonisins are the main mycotoxins responsible for the hepatoto.xic and 
hepatocarcinogenic effects in rats. 
Biomackers or End Points of Fumonisin Toxicity and Carcinogenicity 
Increased plasma or serum total cholesterol (TC) level and alanine 
aminotransferase (ALT) activity have been associated with fumonisin 
hepatotoxicity and hepatocarcinogenicity in several studies. Fusarium 
prolifaracum strain 5991-fermented corn providing 50 ppm FB. to DEN (15 
mg/kg body weight)-initiated F344/N rats significantly increased plasma TC 
and ALT concentrations while causing hepatocellular adenomas (Hendrich et 
al., 1993). Qsing the same chemical carcinogenesis model established in 
that study, i.e. initiation of rats with DEN at 15 mg/kg body weight 
followed by 50 ppm FB. promotion for 4 weeks, Lu et al. (1997) demonstrated 
that FB. caused significant increases in plasma TC concentration and .^JiT 
activity in rats showing development of PGST- and GGT-positive .^HF, early 
indicators of FB. carcinogenesis. 
Increase in low density lipoprotein cholesterol (LDL) probably 
accounted for the major part of the increase in plasma total cholesterol, 
because only LDL, but not high density lipoprotein cholesterol (HDL) or 
very low density lipoprotein cholesterol (VLDL), was significantly raised 
in vervet monkeys fed a low fat (12% of energy), high carbohydrate (72% of 
energy) diet containing 0.25-1% of F. monillforme culture material (Fincham 
et al., 1992). In addition, there was no accumulation of cholesterol in the 
liver. It was therefore proposed that impaired cholesterol removal from the 
plasma rather than increased cholesterol synthesis in the liver probably 
occurred (Fincham. et al., 1992). Whether LDL receptors in the hepatic 
me.mbrane were affected by FB, hepatotoxicity was unknown because t.he 
receptors were not measured in that study. In addition, there was no direct 
evidence that the cholesterol synthesis was not stimulated by FB-,. 
Increase in .^iLT activity generally indicates leakage of this enzyme 
from the hepatocytes as a result of membrane damage due to toxicants, such 
as FB.. 
Fumonisin B.-induced rat hepatocarcinogenesis can be identified by 
changes in PGST e.xpression (Lebepe-Mazur et al., 1995) and GGT activity 
(Gelderblom et al., 1988a), which are markers of AHF (Goldsworthy et al., 
1985; Sato et al., 1984) . Because of the early occurrence of FGST induction 
(within 48 h in single putatively initiated hepatocytes after DEN treatment 
(Moore et al., 1987), and because of the persistence of both PGST and GGT 
during hepatocarcinogenesis (Hendrich et al., 1987), these two enzymes can 
serve as sensitive biomarkers of early stages of cancer development in the 
liver. In support of this view was a study on FB,-induced rat 
hepatocarcinogenesis, in which PGST- and GGT-positive AHF were detected in 
all rats after 4 weeks of 50 ppm FB, treatment following DEN initiation (Lu 
et al., 1997). 
Prostaglandins are a group of lipid molecules synthesized from 
arachidonic acid and released by various normal or cancerous cell types. It 
has been shown that production of prostaglandins from the cycloo.xygenase 
pathway was stimulated in Yoshida hepatoma cells in rats and in human 
hepatocellular carcinomas (Trevisani et al., 1980; Hanai et al., 1993). 
Increases in hepatic prostaglandin F;^ {PGF;,^) and prostaglandin E. (PGE.) 
concentrations were associated with rat hepatocarcinogenesis promoted by 
F3. (Lu et al., 1997). Hepatic prostaglandins F:^ and therefore, can 
also serve as markers of FB, hepatocarcinogenicity. 
Based on t.he finding that FB. inhibited sphingolipid biosynthesis in 
rat primary hepatocytes, it was proposed that exposure to FB. would elevate 
sphinganine to sphingosine ratio (Sa/So) in tissues and serum (Wang et al., 
1991). An increase in serum Sa/So was demonstrated in horses given 44 ppm 
FB.. The ratio was elevated before increases of serum enzymes indicative of 
cellular injury, and it returned to control level when the horses stopped 
eating the FB,-containing feed. When the horses resumed consumption of the 
to.xic feed, the Sa/So ratio became elevated again (Wang et al., 1992). 
Similar results were obtained in pigs fed fumonisins B, and B, at total 
levels of 0, 5, 23, 39, 101 and 175 ppm. The Sa/So ratio was significantly 
raised in liver, lung and kidney from pigs consuming feed containing as low 
as 23 ppm fumonisins. Elevation of the ratio in serum paralleled the 
increase in the tissues. Increases in serum enzymes indicative of tissue 
damages occurred only at 101 ppm and 175 ppm total fumonisins. Tissue 
lesions were observed histologically at >23 ppm in the liver and >175 ppm 
in Che lung, but not in the kidney at any doses of fumonisins (Riley et 
ai., 1993). Dietary FB. also disrupted sphingolipid metabolism in Sprague-
•awley rats in a 4-week feeding study. The concentrations of FB. were 0, 
15, 50 and 150 ppm. The ratio was significantly raised at 50-150 ppm FB. in 
the liver and 15 ppm in the kidney. In serum, a significantly greater Sa/So 
ratio was evident in all rats at 150 ppm FB.. Light microscopic lesions 
were found at 50-150 ppm and 15-50 ppm FB. in the liver and the kidney, 
respectively. Ultrastructural lesions were found at 15 ppm in both the 
liver and the kidney (Riley et al., 1994). When the results from these 
animal studies were taken together, it was concluded that, first, increase 
in the 3a/So ratio was detected before or at the same time as tissue 
lesions; second, there was a dose-response relationship between dietary F3. 
levels and the degree of elevation of the ratio; and third, the increase in 
the ratio was detected prior to elevation of serum enzymes and at lower 
doses. Therefore, the Sa/So ratio was an early biomarker of general 
fumonisin toxicity, or an early indicator of FB. e.xposure. .However, none cf 
the studies linked this ratio to hepatocarcinogenesis. 
Mechanisms of Fumonisin Toxicity and Carcinogenicity 
Extensive research on mechanisms of f'jmonisin toxicity and 
carcinogenicity has been conducted since the discovery of fumonisins. 
The structures of fumonisins resemble those of sphinganine and 
sphingosine, the long-chain backbone of sphingolipids. Wang et al.(1591) 
proposed that the mechanism of action of fumonisins might be via disruption 
of sphingolipid metabolism, i.e. fumonisins might interact with enzymes of 
sphingolipid biosynthesis and turnover. 
In animal cells, the first steps of sphingolipid biosynthesis through 
formation of ceramide take place in the endoplasmic reticulum. One of the 
important reactions is the acylation of sphinganine to dihydroceramide, an 
immediate precursor of ceramide, by ceramide synthase. Subsequent 
biosynthesis of complex sphingolipids, i.e. glycosp.hir.gclipids ar.d 
sphingomyelin, occur in the Golgi apparatus and plasma membrane. Turnover 
of complex sphingolipids in cell membrane begins with internalization of 
sphingolipids, followed by their hydrolysis in acidic compartments 
(e.ndosomes and lysosomes) to release ceramide, which is converted to 
sphingosine. Sphingosine is either reacylated by ceramide synthase to 
ceramide or phosphorylated (Merrill et al., 1993a). 
Studies of effects of FB. on sphingolipid biosynthesis have shown 
that FB. inhibited ceramide synthase, the enzyme responsible for acylation 
of sphinganine in the biosynthetic pathway for sphingolipids as well as the 
reacylation of sphingosine that was released upon sphingolipid turnover. 
The consequences of the inhibition included accumulation of sphinganine, 
increase of Sa/So ratio, and depletion of complex sphingolipids (Merrill et 
al., 1993b; Wang et al., 1991; Yoo et al., 1992) . In primary rat 
hepatocytes, fumonisin B. inhibited ceramide synthase with an IC,, of 0.1 
uM. The concentration of sphinganine rose 110-fold over controls when rat 
hepatocytes were incubated with 1 pM FB. for 4 days (Wang et al., 1991). In 
cultured mouse cerebellar neurons, fumonisin B. inhibited sphingomyelin 
biosynthesis to a greater extent than it inhibited glycolipid biosynt.hesis 
(the IC^„ for inhibition of sphingomyelin biosynthesis was lO-fold lower 
than for glycosphingolipids), suggesting that FB. preferentially inhibited 
complex sphingolipid biosynthesis (Merrill et al., 1993b). In pig renal 
epithelial cell line LLC-PK:, the IC50 of FB, for inhibition of ceramide 
synthase was about 20 pM. Approximately 50-fold and 128-fold increases in 
sphinganine were measured after incubation with FB. (35 pM) for 6 hr and 24 
hr, respectively (Yoo et al., 1992). Although sphingosine level did not 
increase in hepatocytes, it became significantly elevated in LLC-PK-. cells 
(Yoo et al., 1992), suggesting that the reacylation of sphingosine derived 
from sphingolipid turnover was inhibited by FB.. The increased sphingosine 
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may also come from breakdown of membrane lipids in dead cells. In LLC-PK; 
cells, however, the increase occurred before any evidence of cell death 
(Yoo et al., 1992). In spite of that, sphinganine accumulated to a much 
greater extent than sphingosine (Yoo et al., 1992), suggesting that t.he 
i.nhibition of sphinganine acylation was preferable to the inhibition of 
sphingosine reacylation. As a result of this differential inhibition, the 
ratio of sphinganine to sphingosine increased after exposure to FB, (Yoo et 
al., 1992). 
The finding of in vitro inhibition of sphingolipid biosynthesis by 
TB. was e.xtended to in vivo studies. The increases in sphinganine and the 
ratio of Sa/So, and reduction in the amount of complex sphingolipids were 
associated with F3. to.xicity in horses (Wang et al., 1992), pigs (Riley et 
al., 1993), Sprague-Dawley rats (Riley et al., 1994) and other animals. It 
remains unclear, however, whether the disruption of sphingolipid 
biosynthesis after FB, exposure occurs in humans. 
The disruption of sphingolipid biosynthesis can have adverse effects 
on cells because these molecules have important roles in cell membrane 
structure, cell-cell comjnunication, interactions between cells and the 
extracellular matrix, regulation of growth factor receptors, and as second 
messengers for tumor necrosis factor, interleukin 1 and nerve growth factor 
(Merrill et al., 1993a). 
.However, the link between the disruption of sphingolipid biosynthesis 
and FB. toxicity and carcinogenicity has not been elucidated. In addition, 
what causes the species-specific and tissue-specific FBt toxicity and 
carcinogenicity is still unknown. Possible mechanisms of FB, toxicity and 
carcinogenicity via disruption of sphingolipid biosynthesis have been 
proposed such as inhibition of Na /K ATPase, inhibition of protein kinase 
C, release of intracellular Ca , induction of dephosphorylation of 
retinoblastoma protein (a key regulator of G to S phase transition in ceil 
1. 
cycle), induction of apoptosis, activation of epidermal growth factor 
receptor, activation of phospholipase D, activation of AP-1, loss of 
regulation of differentiation, etc. (Merrill et al., i993a,c;. 
Another possible mechanism of FB. toxicity and carcinogenicity 
operates via prostaglandins. Prostaglandin production was stimulated in 
Yoshida hepatoma cells (Trevisani et al., 1980), in human hepatocellular 
carcinomas (Hanai et al., 1993), and in some other types of cancers (Turini 
et al., 1990). Elevated levels of prostaglandins in tumors were believed to 
facilitate tumor cell proliferation (Turini et al., 1990). Experiments i.T 
vivo indicated that prostaglandins were i.mplicated in tumor growth in 
Wistar rats (Trevisani et al., 1980). Prostaglandins may also exert 
indirect effects on proliferation of tumor cells by suppressing the local 
immune response, because prostaglandins were able to maice macrophages 
and/or lymphocytes less sensitive to various stimuli (Pelus and Strausser, 
1977; Schultz et al. , 1978), and PGE_ suppressed NK cells and lymphokine-
activated killer cells (Ohnishi et al., 1991; Roth and Golub, 1993; 
Baxevanis et al., 1993). Elevation of hepatic prostaglandins paralleled the 
induction of AHF in rat liver, indicating that increased prostaglandin 
production was related to promotion of rat hepatocarcinogenesis caused by 
"B. (Lu et al., 1997). 
Fumonisin Bi can alter immunological functions mediating antitumor 
mechanisms. Macrophage structure and phagocytic function were down 
regulated in vitro by FB, (Chatterjee and Mulcherjee, 1994; Chatterjee et 
al., 1995), as was lymphocyte proliferation in response to 
lipopolysaccarides (Dombrink-Kurtzman et al., 1994). The effects of in viva 
administration of FB. produced both increases and decreases in plaque-
forming cell response in BALB/C mice depending upon the timing of the FB, 
i.nfections and the number of injections (Martinova and Merrill, 1995). 
Detoxification of Pumonisins 
The wide spectrum of FB. toxicity and its potential carcinogenic 
effect on humans necessitates development of methods for FB. 
detoxification. Efforts have been devoted to detoxifying FB. in several 
ways. Fumonisin B. is heat stable, because nearly 85% of FB. was recovered 
after various heat treatments: 75°C for 135 min, 100°C for 45 min, and 
i25°C for 5 min. More than 901 of FB. was recovered after 16 h at 50°C 
(Dupuy et al., 1993). 
.A.tmospheric ammoniation of FB.-containing corn was not effective for 
deto.xification. Treatment of the F. moniiijforme-contaminated corn and 
culture material with 2% ammonia at low pressure for 4 days, a process that 
detoxifies aflatoxin B^, led to slight reduction in the concentration in 
the concentration of FB, without decreasing the hepatotoxicity in rats 
(Norred et al., 1991). .^Ammoniation at high pressure (60 psi) and low 
te.mperature (20°C) reduced detectable FB, levels in corn by 79%, but the 
toxicity of the ammoniated corn was not evaluated (Park et al., 1992). 
Ethanol distilled from the whole stillage after fermentation of moldy 
corn for ethanol production did not contain any FB., but most FB. was 
recovered in the distillers grain and thin stillage (Bothast et al., 1992), 
which are often used as animal feed. 
Nixtamalization is a traditional processing of corn with Ca(OH). a.nd 
heat to produce masa (tortilla flour). The processing of corn is used to 
improve the nutritional value by increasing niacin bioavailability in the 
masa. When F. proliferatum-contaminated corn was boiled in 1.2% Ca(OH). 
solution for 1 h, the concentration of FB, was lowered from 50 ppm to 0.4 
ppm, and 7-10 ppm hydrolyzed FB, was produced. This hydrolyzed FB. was 
similar in toxicity to FB, when nutritional status of rats was adequate 
(Hendrich et al., 1993). In agreement with the finding, another study of 
effectiveness of nixtamalization for FB. detoxification showed that 
hydrolyzed FB. at 58 ppm level was similar to Ti pprr. FB, in causing 
hepatotoxicity and nephrotoxicity in rats (Voss et al., 1995). 
In vitro toxicity studies on several analogs of FB. showed that the 
analogs containing FB.'s amine group and the tricarballylic side chains 
were more toxic than FB., whereas the ?nalog containing only the 
tricarballylic side chains was not toxic (Kraus et al., 1992]. The N-acetyl 
derivative of FB. at 1 mM was less toxic in primary rat hepatocytes than 
FB. at the same concentration. In addition, rats fed N-acetyl-FB, at about 
ICOO ppm did not exhibit hepatic neoplastic nodules or increased hepatic 
GGT activity (Gelderblom et al., 1993). Therefore, FB.'s amine group is 
likely to be critical for its toxicity. The N-acetyl-FB. may be produced 
during the isolation and purification of FB. from corn culture materials. 
The most successful FB. detoxification so far has been demonstrated in a 
study in which FB.'s amine group was blocked by reacting with reducing 
sugars such as fructose in a Maillard reaction. Subjecting FB. to 
nonenzymatic browning conditions with fructose eliminated FB. to.xicity and 
carcinogenicity as reflected in body weight, plasma total cholesterol 
concentration, and ALT activity, development of PGST- and GGT-positive .A.KF, 
and hepatic PGF.^ and PGE. levels (Lu et al. , 1997). 
Another approach to inhibiting FB. toxicity and carcinogenicity is in 
close relation to naturally occurring plant constituents, such as soybean 
isoflavones, which possess potential health-protective activities including 
anticarcinogenicity. 
Soybean Isoflavones and Their Contents in Soybean Foods 
Soybeans contain 1-3 mg isoflavones/g (Wang and Murphy, 1994a), and 
are considered a rich and major source of isoflavones. Genistein, daidzein 
and their glycones (glucoside conjugates) are the major isoflavones in 
soybeans (Murphy, 1982) in which the glycones compose 97-98% of total 
isoflavones (Wang and Murphy, 1994b). Twelve soybean isoflavone isomers 
have been identified, including glucoside conjugates genistin, daidzin, 
glycitin, 6"-0-acetylgenistin, 6"-0-acetyldaidzin, 6"-0-acetylglycitin, 6"-
0-malonylgenistin, 6"-0-malonyldaidzin, 6"-0-malonylglycitin, and their 
corresponding aglycones, genistein, daidzein and glycitein (Kudou et al. , 
1991) . 
Soybean isoflavones are present in the range of 0.2-1.5 mg/g in 
commercial soybean foods (Wang and Murphy, 1994b). Similar to unprocessed 
soybeans (total isoflavone levels at 1.2-4.2 mg/g), high-protein soybean 
ingredients, such as soy flour and te.xtured soy protein, contained 1.1-1.4 
mg/g of total isoflavone concentrations. Soy concentrate, however, had very 
low isoflavone levels because alcohol washing removed most of the 
isoflavones from soy flakes. There was a major difference in the forms of 
isoflavones in traditional soybean foods. Nonfermented soybean foods, such 
as tofu and soymilk powder, had greater levels of glucoside conjugates of 
isoflavones, whereas in fermented soy foods (e.g. tempeh and miso), the 
isoflavone aglycones, genistein and daidzein, predominated because of the 
hydrolysis by bacterial glucosidases during fermentation. Second-generation 
soybean foods such as tofu yogurt and soy bacon contained only 6-20% of the 
isoflavones found in whole soybeans, because soy ingredients were minor 
components used as replacement for animal protein and fat (Wang and Murphy, 
i994b). 
Bioavailability and Metabolism of Soybean Isoflavones 
Soybean isoflavones have been considered to possess cancer-protective 
potential. To understand bioavailability of isoflavones in humans, whi^li is 
critical in determining the approximate amount of dietary isoflavones 
needed to maintain functional levels of isoflavones in the body, Kendrich 
and associates conducted a series of bioavailability studies of soybean 
isoflavones in adult women (Xu et al., 1994; Tew et al., 1996a,b). At all 
three doses of soymilk isoflavones (O.'', 1.3 and 2.0 mg/kg body weight!. 
average 24 h urinary excretion of daidzein and genistein was approxiniateiy 
211 and 9%, respectively, of a single ingested dose. Approximately 1-2'^ of 
ingested isoflavones were excreted in feces. The average amount of urinary 
daidzein and genistein increased significantly in a dose-dependent fashion. 
The plasma total isoflavone concentration, i.e. 4.4 ± 2.5 pM at 6.5 h after 
a dose of 2.0 mg/kg, suggested that although 85s of soymilk isoflavones 
seemed to be degraded in the intestine, they might be present in sufficient 
amounts in blood to exert their health-protective effects (Xu et al., 
1994). To understand whether t.he bioavailability of isoflavones would be 
affected by some dietary factors. Tew et al. (1996a,b) studied the effects 
of dietary fat and fiber content on soy isoflavone bioavailability in 
humans. In the first study, seven healthy women were given low or high fat 
diet (201 or 40% of energy from fat) containing a single dose of 0.9 mg 
isoflavones/kg body weight from tofu or texturized vegetable protein (TVP). 
The amount of dietary fat intake did not affect bioavailability as 
reflected on 24 h urinary isoflavone recovery (Tew et al., 1996a). In the 
second study, seven healthy women were fed a control diet or a wheat fiber 
supplemented diet (15 g and 40 g of dietary fiber, respectively) with a 
single dose of 0.9 mg isoflavones/kg body weight from tofu or TVP. The 
fiber-rich diet decreased plasma genistein at 24 h after dosing by 55% and 
reduced total urinary genistein by 20%. Therefore, dietary fiber content 
should be taken into account to determine the bioavailability of soybean 
isoflavones (Tew et al., 1996b). 
Upon ingestion the glucoside conjugates of daidzein and genistein 
(daidzin and genistin) are hydrolyzed in the large intestine by intestinal 
bacteria to release the unconjugated daidzein and genistein (Setchell et 
al., 1984). The extent of absorption may be dependent on the chemical form 
of the isoflavones, with the aglycones more readily absorbed than their 
corresponding glucoside conjugates, because the latter are very polar. 
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Absorbed soybean isoflavones are transported via the hepatic portal 
vein to the liver, where they are rapidly conjugated with glucuronic acid 
and, to a much lesser extent, with sulfuric acid (Setchell et al., 1984). 
The glucuronides are excreted into either bile or urine, depending on the 
molecular weight and the polarity of the aglycones. The glucuronide 
conjugates of genistein and daidzein can be excreted into bile or urine in 
rats. Sulfate conjugates are readily excreted into urine. The glucuronide 
isoflavones which are excreted into bile enter the GI tract. Beta-
glucuronidases in lower GI tract deconjugate isoflavones, so the isoflavone 
aglycones might undergo efficient enterohepatic circulation (Larsen, 1988). 
In both plasma and urine, isoflavones are primarily glucuronide conjugates, 
whereas in feces, isoflavones are predominantly found in the unconjugated 
form. The free and sulfate forms of isoflavones in plasma are biologically 
active (Adlercreutz et al., 1993a). It is still under investigation whether 
the glucuronide form of isoflavones is also biologically active. 
Estrogenic and Antiestrogenic Activities of Isoflavones 
Isoflavones are heterocyclic phenols resembling the structure of 
estrogen. The C-7 and C-4' hydroxyl groups of genistein and daidzein, which 
correspond to the C-3 and C-17 hydroxyl groups of 17 beta-estrodiol, are 
necessary for their estrogenicity via binding estrogen receptor; and the 
additional C-5 hydroxyl group of genistein may increase estrogenic activity 
(Miksicek, 1995). Isoflavones have very weak estrogenic effects, ranging 
from 10*" to 10"^ that of diethylstilbestrol (DES) or estradiol 
(Farmakalidis et al., 1985; Santell et al., 1997). The grov/th of uterus, 
mammary glands and vagina of immature or ovariectomized animals is 
frequently used as a parameter to evaluate the weak estrogenicity of 
isoflavones (Farmakalidis et al., 1985; Folman and Pope, 1966; Santell et 
al., 1997) . Farmakalidis et al. (1985) compared the estrogenic potencies of 
genistin, genistein and daidzin with that of DES in the B6D2F1 strain of 
mouse. The compounds were administered by stomach intubation. The increase 
in uterine weight over control was taken to rank their reiati'/e estrogenic 
potencies. When the relative potency was assigned as 1.00 for genistein, it 
was 0.66, 0.26 and 100,000 for genistin, daidzin and DES, respectively. 
The weak estrogenic effects of isoflavones act through estrogen 
receptor. Relative binding affinity of genistein for the rat uterine 
estrogen receptor was about 10"' that of estradiol (Santell et al., 1997). 
In addition, uterine e.xpression of c-fos, which is an estrogen-responsive 
gene (Weisz and Resales, 1990), was induced in ovariectomized Sprague-
Dawley rats following the dietary administration of genistein {750 mg/kg 
diet for 14 days) or estradiol (1 mg/kg diet for 14 days). The induction of 
c-fas by genistein and the binding assay of the estrogen receptor suggested 
that isoflavones induced a weak estrogenic response by interacting with the 
estrogen receptor and were capable of initiating the biological response by 
forming an active complex with the receptor in uterine tissue (Santell et 
al., 1997). In support of this interpretation, genistein was also shown to 
stimulate estrogen-responsive pS2 mRNA expression in estrogen receptor 
positive human breast cancer cell line MCF-7 at concentrations as low as 
10~° M, and the stimulation of pS2 expression by genistein (lO""' M) was 
blocked by the addition of tamoxifen (10~^ M), an antiestrogen (Wang et 
al., 1996). 
However, genistein injected subcutaneously at large dose (1.6 mg) was 
shown to inhibit DES-stimulated vaginal and uterine growth by approximately 
40% in immature female albino mice of the BSVS strain. Therefore it was 
concluded that isoflavones might act as antiestrogens (Folman and Pope, 
1966). A similar conclusion was drawn from another study in which 
injections of 0.3 and 0.9 mg of genistein, when administered simultaneously 
with estradiol, decreased mouse uterine estradiol uptake by 71% and 95%, 
respectively, and vaginal estradiol uptake by 70% and 89%, respectively 
(Folman and Pope, 1969). 
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The apparent antiestrogenicity of isoflavones may result from a 
combination of multiple effects. The primary one is likely to be the 
competitive binding to estrogen receptor. Isoflavones were shown to compete 
with estradiol for binding to the estrogen receptor with relative binding 
affinity of 10 " to 10 that of estradiol (Shutt and Cox, 1972; Verdeal et 
al., 1980), but they were less effective than estradiol in translocating 
the cytoplasmic estrogen receptor to the nucleus (Martin et al., 1978), and 
they failed to initiate effective cytoplasmic receptor replenishment (Tang 
and Adams, 1980). Isoflavones may inhibit estrogen synthetase (aromatase), 
a cytochrome P-450 enzyme that catalyzes the conversion of androgen to 
estrogen in many tissues (Adlercreutz et al., 1993b). It was reported that 
daidzei.n and its metabolite equol inhibited human placental aromatase in 
microsomal preparation from human placenta, with IC.^ of <1 mM and 150 (iM, 
respectively (Adlercreutz et al., 1993b). Isoflavones may also decrease the 
amount of free and active estrogen in the blood by stimulating sex hormone 
bi.nding globulin (SHBG) synthesis (Adlercreutz et al., 1990). Sex hormone 
binding globulin binds dihydrotestosterone, testosterone and estradiol in 
order of decreased affinity (Rosner, 1990). High SHBG level .may reduce risk 
of hormone-related cancers, because SHBG regulates clearance and uptake of 
estrogen {Mousavi and Adlercreutz, 1993), which at physiological 
concentrations stimulates growth of human breast cancer cells (Horowitz and 
McGuire, 1978). In human hepatocarcinoma cells (Hep-G2), genistein at 5-30 
ViM significantly increased the production of SHBG without showing 
cytotoxicity (Mousavi and Adlercreutz, 1993). Therefore, isoflavones may 
e.xert antiestrogenic effects in animals through competing with estradiol 
for the occupancy of the estrogen receptor, inhibiting estradiol synthesis 
and decreasing availability of free estradiol in the blood. 
Whether isoflavones are estrogenic or antiestrogenic probably depends 
on the amounts of exogenous isoflavones vs. the concentration of endogenous 
estradiol, and on the sensitivity of target tissues to these compounds. 
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Afcer ingestion of a relatively large amount; of soy foods, urinary 
excretion and plasma concentrations of isoflavones may well exceed 
endogenous estrogen levels. For example, urinary levels of estrone 
glucuronide, the principle estrogen in the urine, reached 2 to 27 ug/day 
during the follicular phase of menstrual cycle (Setchell et al., 1984), but 
urinary excretion of isoflavones was 0.35 to 7.49 mg/day after a 60 g soy 
protein diet providing 45 mg isoflavones (Cassidy et al., 1994), which was 
in agreement with 24 h urinary excretion levels in humans reported by Xu et 
al. (1994). In that isoflavone dose-response study, at a single dose of 0." 
mg soymilk isoflavones/kg body weight, representing an average intake of 44 
mg total isoflavones, the average 24 h urinary excretion of isoflavones was 
5.93 mg, and the excreted amounts increased with larger doses of scymilk 
isoflavones (Xu et al., 1994). At these levels of dietary intake, which are 
well within the range of average isoflavone consumption in Asian countries 
(50-100 mg isoflavones/day, Adlercreutz et al., 1991; Coward et al., 1993), 
urinary excretion and plasma concentrations of isoflavones may be several 
orders of magnitude higher than endogenous estrogen. Thus isoflavones seem 
to be antiestrogenic in .humans. This is indirectly confirmed by the 
findings that daily consumption of soy protein containing 45 mg for 1 mont.h 
by premenopausal women led to prolonged menstrual cycle and altered 
hormonal status, the responses that also occurred with tamo.xifen, an 
antiestrogen for treating breast cancer (Cassidy et al., 1994). However, 
whether the antiestrogenicity of isoflavones is associated with health-
beneficial effects such as cancer prevention in humans in uncertain. 
Isoflavones as Antioxidants 
Isoflavones are antio.xidants. The antio.xidative activity of 
isoflavones is obviously attributed to their hydroxyl groups. Inhibition by 
10 M isoflavones of linoleate oxidation was 70%, 30%, 26% and 15% for 
genistein, genistin, daidzein and daidzin, respectively. Therefore, the 
antio.xidative capacity was seemingly greatest for genistein followed by 
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genistin, daidzein and daidzin (Prate and Birac, 1979). Wei et ai. (1993! 
reported that genistein (1-150 pM) decreased tumor promoter-stimulated 
production of hydrogen peroxide {H,0.) in human polymorphonuclear 
leukocytes and HL-60 cells in a dose-dependent manner, with of 14.3 
and 30.2 uM, respectively. In a subsequent study, effects of isoflavcnes 
and related flavones on H,0, formation were compared in tumor promoter-
activated HL-60 cells, i^mcng the tested compounds at concentrations of 10, 
50, 100 and 200 pM, genistein (IC;q = 25 pM) and daidzein IIC~: = 150 uM) 
were the most potent inhibitors (Wei et al., 1995). In addition, topically 
applied genistein (0.05 to 50 mM in acetone) inhibited H.O, formation in 
CD-I mouse skin by 31-117% (Wei et al., 1993), and feeding 250 ppm 
genistein to CD-I mice for 30 days significantly increased the activities 
of antio.xidant enzymes including catalase, superoxide dismutase, 
glutathione peroxidase in the skin and the small intestine by 10-30'^ (Wei 
at al., 1995). In rat peritoneal leukocytes stimulated by calcium ionophor 
.-23187, certain flavonoids inhibited eicosanoid production via 5-
lipoxygenase and cyclooxygenase pathways with IC;3 of 1-180 nM. The 
presence of the hydroxyl groups seemed to be critical to the inhibitory 
effects (Moroney et al., 1988). Because isoflavones belong to flavonoids 
and are structurally similar to those tested compounds, genistein and 
daidzein may also suppress syntheses of eicosanoids including 
prostaglandins. 
Anticarcinogenxcity of Soybean Isoflavones 
Epidemiological studies have shown that soybean consumption is 
greater in some .i\sian countries where risk of hormone-dependent cancers is 
relatively low (Reviewed by Adlercreutz et al., 1995a). The amounts of 
dietary intake of soybean products can be reflected accordingly in plasma, 
urine and feces. Urinary excretion of isoflavones is much greater in 
Japanese men and women consuming a traditional soy-rich diet compared with 
that in women from Boston and Helsinki (Adlercreutz et al., 1986 and 1991;. 
Plasma levels of biologically active isoflavones (free and sulfate forms) 
were 10-20 times higher in Japanese men than those in Finnish males 
{Adlercreutz et al., 1993c). Fecal excretion of isoflavones in Finnish 
women was 5-17 times greater in vegetarians than in omnivores (.Adlercreutz 
et al., 1995b). The incide.nce cf breast cancer in the oriental countries is 
5-S times lower than that in the U.S. (Nagasawa, 1980), where soybeans only 
contribute to a very small part of a conventional American diet. However, 
the incidence of breast cancer in .Asian immigrants in the U.S. and their 
following generations approaches the typical incidence rates of U.S. women 
•Buell, 19''3) . These findings stimulated interest in the possibility that 
soybean consumption might prevent the development of breast cancer. 
The speculated anticarcinogenic effects of soy feeding have been 
confirmed in animal studies. Feeding soy protein isolate to rats 
significantly decreased tumor incidence by 50% and noticeably increased 
latency in an M-methyl-N-nitrosouria (NMU) model of breast cancer 
(Hawrylewicz et al., 1991). Compared with chow-fed and casein-fed rats, 
those fed a diet containing 50% raw soybeans had a significantly lower 
incidence of X-ray irradiation-induced adenocarcinomas and fibroadenomas in 
.mammary glands (Troll et al., 1980). Barnes et al. (1990) found that both 
autoclaved and nonautoclaved whole soybeans (10% and 20%) and soy protein 
isolate reduced the number of mammary tumors induced by both direct-acting 
(NMU) and indirect-acting (7,12-dimethylbenz[a]anthracene, DMBA) 
carcinogens. In addition to breast cancer, hepatocarcinogenesis is also 
inhibited by soy consumption in animals. Feeding a diet containing 30% 
autoclaved soybeans significantly decreased ultrastructural changes induced 
by dibutylamine and nitrite in rat liver (Fitzsimons et al., 1989). 
Soybean isoflavones may contribute in large part to the 
anticarcinogenic effects associated with soybean feeding. In F344/N rats 
initiated with DEM (15 mg/kg body weight) and promoted by phenobarbital 
(500 mg/kg diet), soybean iscflavone extract providing 1 rwnol or 2 m-tici 
iscflavones/kg diet suppressed phenobarbital-promoted hepatocarcinogenesis 
as evidenced by the decreased volume percentage of GGT- and PGST-positive 
AHF after 3 months of feeding (Lee et al., 1995). Using a DEN 
initiation/FB. promotion carcinogenesis model, Hendrich et al. (1997) 
demonstrated that feeding isoflavone extract (1 mmol isoflavones/kg diet) 
suppressed PGST-positive AHF by over 50%. In that study, the isoflavone 
extract was prepared from roasted and defatted soy flakes by acetone 
extraction. These steps of preparation could have removed other proposed 
anticarcinogenic soy constituents such as saponins and 3owman-Birk protease 
inhibitor. Therefore, soybean isoflavones were very likely responsible for 
the protective effect against cancer. This speculation was supported by an 
observation that feeding genistein to rats in the perinatal period delayed 
the appearance of breast cancer after the pups were administered DMB.A at 50 
days of age (Lamartiniere et al., 1995). 
Several mechanisms have been proposed to explain the 
anticarcinogenicity of isoflavones in animals. Since estrogen has been 
shown to stim.ulate human breast cancer cells at physiological 
concentrations (Horowitz and McGuire, 1978), isoflavones may be 
anticarcinogenic by acting as antiestrogens (Setchell et al., 1984). 
Originally, the antiestrogenicity of isoflavones was only thought to be 
related to the estrogen receptor, but now this activity may be considered 
to be due to several effects: competitive binding to the estrogen receptor 
(Shutt and Cox, 1972; Verdeal et al., 1980), inhibition of estrogen 
synthetase (aromatase) (Adlercreutz et al., 1993b) and stimulation of SHBG 
synthesis (Mousavi and A.dlercreut2, 1993) . 
The antiestrogenic effect of isoflavones through competition with 
estradiol for binding to the estrogen receptor, however, did not seem, to be 
associated with the antiproliferative effect of isoflavones in vitro. Wana 
et al. (1996) reported that genistein exerted a concentration-dependent 
biphasic effect on the proliferation of an estrogen receptor-positive human 
breast cancer cell line MCF-7: at lower concentrations (10"' to 10"'' M) , 
genistein stimulated growth, but at higher concentrations (>10"' M) , 
genistein was inhibitory to growth. The cell proliferative effect of 
isoflavones was mediated through the estrogen receptor, but their 
antiproliferative effect was independent of the estrogen receptor, because 
in the estrogen receptor-negative MDA-MB-23 cells, genistein did not 
stimulate cell growth at lower concentrations (<10' M) , whereas it was 
still inhibitory to cell growth at higher concentrations ranging from 10" 
to 10"' M. In support of this finding, another study showed that genistein 
was inhibitory to the proliferation of both estrogen receptor-positive 
(MCr-7) and -negative (MDA-468) breast cancer cell lines at similar IC^,: 
24 to 44 uM (Peterson and Barnes, 1991). 
At high concentrations (>10~^ M for genistein), the estrogen 
receptor-independent antiproliferative effect of isoflavones may be 
attributed to other mechanisms, which involve protein tyrosine kinases. 
So.me peptide growth factor receptors have intrinsic tyrosine kinase 
activity. For e.xample, protein tyrosine kinase activity is associated with 
receptors for epidermal growth factor (EGF), insulin-like growth factor I, 
platelet-derived growth factor and mononuclear phagocyte growth factor. 
Tyrosine kinases are important for cell proliferation, in that activation 
of certain peptide growth factor receptors requires autophosphorylation at 
tyrosine residues (Akiyama et al., 1987). Genistein is a specific inhibitor 
of protein tyrosine kinases. It was shown that genistein specifically 
inhibited the autophosphorylation of purified EGF in membrane preparations 
with an IC,^ of 2.6 pM (Akiyama et al., 1987). Therefore, genistein may 
elicit antiproliferative effect on cells via inhibition of protein tyrosine 
activity associated with EGF receptor (Peterson and Barnes, 1993). 
To test this hypothesis, the effects of genisteia or. tumor cell 
growth and EGF receptor protein tyrosine kinase activity were evaluated in 
tumor cell lines. Genistein, however, did not inhibit the activation of t.he 
grov/t.h factor receptor in tumor ceils, because genistein did not block EGF 
receptor autophosphorylation in DU-145 prostate cancer cells (Peterson and 
Barnes, 1993). In contrast, tyrphostin, a synthetic tyrosine kinase 
inhibitor which suppressed EGF-stimulated prostate cancer ceil growth with 
a similar to that of genistein, fully blocked EGF receptor tyrosine 
autophosphorylation (Peterson and Barnes, 1993). These results suggested 
that the cellular target of genistein's antiproliferative activity was 
located down-stream from EGF receptor activation in related signal 
transduction pathways. This view was substantiated by a more recent study 
showing that genistein inhibited fetal bovine serum-, estradiol-, and EGF-
stimulated cell growth in 5 different breast cancer cell lines (estrogen 
receptor-positive or -negative) with IC^. ranging from 9.6 to over 74 uM. 
The antiproliferative effect of genistein was not accompanied by inhibition 
of EGF-induced tyrosine autophosphorylation. It was t.herefore concluded 
that the genistein-elicited cell growth inhibition did not depena on 
estrogen receptor or i.nhibition of EGF receptor protein tyrosine kinase 
activity (Peterson and Barnes, 1996). 
But genistein may block cancer cell growth by interfering with 
estradiol- or growth factors-stimulated signal transduction pathways 
leading to cell proliferation. In human colon carcinoma-derived Caco-2 cell 
line, which was estradiol responsive, estradiol stimulated cell growth and 
activated 4 intermediates in a signal transduction pathway known to trigger 
cell proliferation: 2 tyrosine kinases, c-src and c-yes, which belong to a 
c-src-related tyrosine kinase family; and 2 serine/threonine kinases, erk-1 
and erk-2, which are mitogen-activated protein kinases (MAP). The tyrosine 
kinases c-src and c-yes were up-stream from MAP kinases and cell 
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proliferation, because genistein (80 |iM) blocked the stimulatory effects of 
estradiol (10 nM) on both erk-Z activity and cell proliferation through 
inhibition of the tyrosine kinases. It was considered that estradiol 
activated the c-src, c-yes/MAP kinase signal transduction pathway which was 
also a target of various peptide growth factors (Di Domenico et al., 1996). 
If both estradiol and EGF can activate this pathway to exert their cell 
proliferative effects, and genistein can selectively inhibit the tyrosine 
kinase intermediates in the pathway, the estradiol receptor- and EGF 
receptor-independent antiproliferative effect of genistein could be 
e.xplained. In support of this view, the IC50 values for estradiol-
stimulated breast cancer cell growth (2.3-2.7 uM) were similar to those for 
SGF-stimulated growth (2.8-5.4 (iM) (Peterson and Barnes, 1996). 
Genistein was also an effective inhibitor of eukaryotic DNA 
topoisomerase II, an enzyme involved in cellular replication (Markovits et 
al., 1989). The in.hibition was accomplished by stabilizing DNA-
topoisomerase II complex, and the stabilization of the complex in tumor 
ceils caused double- and single-strand breaks in DNA, leading to growth 
inhibition and differentiation (Constantinou et al., 1995). In human 
promyelocytic HL-60 and erythroid K-562 leukemia cells and in human SK-MEL-
131 .melanoma cell lines, an IC^,^ of approximately 37 to 56 pM was observed 
for genistein to inhibit cell growth; and at the same concentrations, 
genistein induced cell differentiation identified by appearance of 
characteristic markers; both single- and double-strand DNA breaks were 
evident after 24 h treatment with the same concentrations required to 
inhibit cell growth and induce cell differentiation (Constantinou et al., 
1995). 
Genistein was shown to inhibit basic fibroblast growth factor-
stimulated proliferation of bovine brain-derived capillary endothelial 
cells and in vitro angiogenesis at IC^, of 5 and 150 pM, respectively 
(Fotsis et al., 1993). This is an interesting finding i.n regard to the 
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anticancer activity of isoflavones, because unregulated angiogenesis or 
neovascularization was associated with tumor growth and metastasis iWeidner 
et al., 1991) . 
Isoflavones may elicit their anticancer effects through an 
antioxidant mechanism. Isoflavones are antioxidants because of the presence 
of their hydroxyl groups. Isoflavones may prevent o.^idative damage by 
inhibiting the formation of free radicals (Wei et al., 1993) and thus may 
contribute to their anticancer activity. The ability of some flavonoids to 
inhibit prostaglandin synthesis may be one of mechanisms by which 
isoflavones exert anticarcinogenic effects. In rat peritoneal leukocytes 
stimulated by calcium ionophore A23187, certain flavonoids inhibited 
eicosanoid production via 5-lipo.xygenase and cyclooxygenase pathways with 
ICc; of 1-180 |iM. The presence of the hydroxyl groups seemed to be critical 
to the inhibitory effect (Moroney et al., 1988). Because isoflavones belong 
to flavonoids and their structures are similar to those of the tested 
compounds, genistein and daidzein may also suppress prostaglandin 
production. Prostaglandins of the F series stimulated the proliferation of 
neonatal rat hepatocytes (Armato and .Andreis, 1983). Inhibition of 
prostaglandin synthesis by indomethacin, a cyclooxygenase inhibitor, played 
a role in suppressing tumor growth in vivo and prolonging survival time of 
hepatoma-bearing rats by appro.ximately 50% (Trevisani et al., 1980). 
Isoflavones may also diminish growth-stimulatory effect of 
prostaglandins. Macphee et al. (1984) have reported that PGF;^ at 300 ng/ml 
stimulated phosphatidylinositol turnover which led to increase in 1,2 
diacylglycerol (DAG) in resting Swiss 3T3 cells, and this event was 
associated wit.h the stimulatory effect of PGF;^ (250 ng/ml) on DNA 
synthesis. .A study of mechanism underlying growth-stimulatory effect of 
prostaglandins in primary hepatocytes shows that prostaglandins stimulated 
DN.A synthesis and increased intracellular inositol-1, 4, 5-triphosphate (I? j 
at concentrations ranging from 10"' to lO*" uM, and elicited elevation of 
free cycosolic Ca"' at lO"' uM. The prostaglandin-stimulated DNA synthesis 
was independent of cAMP, but was at least partly dependent on phospholipase 
C {Refsnes et al., 1995). Isoflavones may suppress prostaglandin-stimulated 
•NA synthesis and thus cell proliferation, because genistein and daidzein 
suppressed phospholipase C activation, resulting in decreased formation of 
inositol phosphates in 3T3 cells (ICj^ = 2.2 and 7.9 pM for genistein and 
daidzein, respectively) (Higashi and Ogawara, 1992). The inhibition of 
phosphatidyl inositol 4,5-bisphosphate (PIP.) hydrolysis via inactivation 
of phospholipase C by genistein and daidzein may decrease prostaglandin 
production as well. This is because arachidonic acid, which is the 
prostaglandin precursor and occupies the 2-pcsition on the glycerol 
backbone of PIP., can be released from the sequential hydrolysis of PI?, by 
phospholipase C and diacylglycerol lipase. Therefore, isoflavones may 
decrease prostaglandin production and dim.inish prostaglandin-stimulated DN.A 
synthesis by inhibiting phospholipase C. 
There has been increasing emphasis on the importance of using 
physiologically achievable isoflavone concentrations in cancer prevention 
studies. Some studies on the mechanisms by which soybean isoflavones 
inhibit carcinogenesis may have overlooked physiological relevance with 
respect to the reported isoflavone concentrations. Some proposed anticancer 
mechanisms of isoflavones may not operate in humans, because the required 
isoflavone concentrations seem to well exceed the physiologically 
achievable levels in the blood. For example, the IC^,^ required for 
genistein to inhibit angiogenesis in vitro was 150 pM, or 1.5 10"" M 
(Fotsis et al., 1993), whereas the plasma isoflavone concentrations 
reported in women (19-41 years of age) consuming soymilk isoflavones only 
ranged from 1 to 5 pM at 6.5 h after single doses of 0.7, 0.9, 1.3 and 2.0 
mg isoflavones/kg body weight (Tew et al., 1996a; Xu et al., 1994), and 
from 0.55 to 0.86 uM after two-week feeding of isoflavones (Barnes et al., 
1996). It was suggested that only those mechanisms requiring isoflavone 
concentrations below 18 uM were likely to be physiologically relevant 
(Barnes and Peterson, 1995). This concentration, 18 pM, however, may still 
not be physiologically achievable. Some researchers believed that even with 
increased intake of soy products, the circulating levels of genistein did 
not exceed 1 pM (Wang et al., 1996). 
The probable anticarcinogenic effect of isoflavones is usually 
represented by their antiproliferative activity in a variety of cell lines. 
A concentration of >10"' M seemed to be required for isoflavones 
(genistein) to be antiproliferative (Constantinou et al., 1995; Fotsis et 
al., 1993; Mousavi and Adlercreutz, 1993; Peterson and Barnes, 1991 and 
1996; Wang et al., 1996). This isoflavone concentration is probably at the 
high end of the physiologically achievable concentration range in humans. 
Since there is large variation in isoflavone content of biological samples 
among human subjects {Xu et al., 1994), in other v;ords, the difference in 
isoflavone bioavailability is substantial among humans, those with greater 
circulating isoflavone concentrations after soy consumption may benefit 
more from the potential anticarcinogenic effects of isoflavones. To 
maintain greater plasma concentration of isoflavones, frequent (daily) soy 
consumption may be needed, because there is little evidence for retention 
of isoflavones in the human body. One study showed that 24 h after a single 
dose of soymilk isoflavones, isoflavones were nearly undetectable in both 
the blood and the urine (Xu et al., 1994). 
The growth inhibition of cells by isoflavones is cytostatic and 
reversible at their IC.,. At higher concentrations, however, genistein is 
cytotoxic (Fotsis et al., 1993; Mousavi and Adlercreutz, 1993; Peterson and 
Barnes, 1996). Although the therapeutic index of genistein cannot be 
calculated due to lack of information on toxic dosage causing 50% cell 
death in those studies, the ratio of minimum to.xic concentration to IC=- is 
The relevance of the in vitro studies in understanding the potential 
cancer-preventive effects of isoflavones is unknown. As mentioned above, 
many of the experiments are conducted using high concentrations of 
isoflavones and few of the proposed anticarcinogenic mechanisms of 
isoflavones in cancer cells may operate at physiological plasma 
concentrations. 
Human cancer cell lines such as MCF-7 have been extensively used in 
the majority of the in vitro experiments with isoflavones. To understand 
the physiological effects of isoflavones on normal cell proliferation, 
Traganos et al. (1992) compared growth inhibition by genistein of norm.al 
human lymphocytes, human leukemic MOLT-4 and HL-60 cells. Genistein showed 
greater antiproliferation in the leukemic cells (IC^, = 31 and 48 uM for 
HL-60 and MOLT-4, respectively) than in the normal lymphocytes (IC^, = 741 
u.M) . T.hus, the sensitivity of normal cells and cancer cells to the growth-
inhibitory effect of isoflavones seemed to be different. The same 
interpretation was given by a recent study examini.ng the differential 
sensitivity of normal human .mammary epithelial cells and human breast 
cancer cells MCF-7 to growth inhibition by genistein and biochanin A, a 
genistein precursor (Peterson et al., 1996). In the normal cells genistei.n 
was 5-fold more potent as a growth inhibitor than biochanin A, but in MCF-^ 
cells biochanin A was as potent as genistein to be antiproliferative. 
Biotransformation of both isoflavones differed in the two kinds of cells. 
The MCF-7 cells produced 2 genistein metabolites and 3 biochanin A 
-metabolites. Two of the biochanin A metabolites were the same as the 
genistein metabolites, and the third one was genistein. In contrast, 
significant genistein or biochanin A biotransformation was not found in the 
normal cells. The difference in biotransformation could be responsible for 
the difference in growth inhibition: the MCF-7 cells were less sensitive to 
genistein inhibition than the normal cells; in contrast, the MCF-7 cells 
were more sensitive to biochanin ,A inhibition than the normal cells 
(Peterson et ai., 1S96). The significance of these findings is yet to be 
determined. On one hand, cancer cells inactivate genistein to a less potent 
growth inhibitor via biotransformation. On the other hand, cancer cells 
activate biochanin A to a more potent growth inhibitor through 
biotransformation. Maybe the self-protective role that cancer cells play 
against genistein inhibition is more significant for themselves, because 
genistein is the major isoflavone in soybeans. 
The Link Between Isoflavones and FBi Detoxification 
The FB: toxicity and carcinogenicity may be diminished by 
isoflavones. It has been shown that FB- caused hypercholesterolemia in 
vervet monkeys (Fincham et al., 1992), but feeding soy isolate containing 
approximately 340 mg isoflavones/kg diet, however, lowered plasma TC and 
LDL + VLDL concentrations by 22-27% and 30-40%, respectively, in rhesus 
monkeys as compared with feeding soy isolate with isoflavones removed by 
ethanol extraction (Anthony et al., 1996). Both the FBi-caused 
hypercholesterolemia and the isoflavone feeding-induced hypocholesterolemia 
seem to be primarily due to changes in plasma LDL, because plasma HDL and 
VLDL remained basically unchanged. This suggests t.hat LDL receptor activity 
may be decreased by FB:^ but increased by isoflavones, so t.hat the LDL 
removal from the blood is affected. Since the increased plasma TC is 
associated with FB;-promoted hepatocarcinogenesis, it is possible that soy 
isoflavones counteract FEi hepatotoxicity and hepatocarcinogenicity by 
suppressing plasma TC. 
Isoflavones may inhibit FB; carcinogenicity by diminishing the FB;-
stimulated DNA synthesis via inositol phosphate pathway, and probably by 
suppressing the prostaglandin formation as well. As mentioned above, 
phospholipase C is likely to be a target of isoflavones for blocking the 
release of arachidonic acid from PIP,. The arachidonate release may be an 
important control point of prostaglandin synthesis (Smith, 1989). The major 
sources of arachidonate, however, are probably the most abundant 
glycerophospholipids, phosphatidylcholine and phosphatidylethanclaniine, 
which are hydroiyzed by phospholipase A: to release arachidonic acid 
(Smith, 1989). Certain flavonoids produced dose-dependent inhibition of 
snake venom phospholipase A; in the concentration range of 5 to 500 nM 
(Alcaraz and Hoult, 1985). Since isoflavones are flavonoids, they may 
decrease prostaglandin production by suppressing phospholipase A;. In 
addition, isoflavones may produce inhibition on cyclooxygenase to block 
prostaglandin synthesis, because some flavonoids were shown to exert 
inhibitory effect on cyclooxygenase and prostanoid production (Moroney et 
al., 1983) . 
As protein tyrosine kinase inhibitors, isoflavones may also inhibit 
rS-.-promoted hepatocarcinogenesis by suppressing DNA. synthesis in 
hepatocytes. Genistein was shown to inhibit DNA synthesis elicited by human 
hepatocyte growth factor (HGF) in rat primary hepatocytes (Arakaki et al., 
1992). The early events of the HGF-mediated signal transduction pathways 
leading to increased DNA synthesis included elevation of IPi and 
intracellular Ca^" concentrations, and were dependent on protein tyrosine 
kinase activity (Baffy et al., 1992). The stimulation of DNA synthesis by 
-HGF, however, was potentiated by 1-(5-isoquinolinesulfonyl}-2-
.raethylpiperazine (Arakaki et al., 1992), an inhibitor of protein kinase C 
(PKC) which is a serine/threonine kinase. This is intriguing, because FB; 
also seems to be a PKC inhibitor. Fumonisin Bi increased sphingosine 
concentration in vitro and in vivo (Riley et al., 1994; Yoo et al., 1992), 
and disruption of sphingolipid metabolism was related to stimulation of DNA 
synthesis by FB, in Swiss 3T3 cells (IC50 = 10 pM) (Schroeder et al. , 1994) . 
Since FB, is structurally similar to sphingosine, a potent PKC inhibitor 
(Wang et al., 1991), it was hypothesized that FB, might suppress PKC 
activity as well (Huang et al., 1995). The hypothesis was supported by the 
rinding that FB, inhibited PKC activity in a dose-dependent manner (IC,, = 1 
uM) in a monkey kidney cell line CV-1 (Huang et al., 1995). 3ased on -he 
fact that the concentration required for 50% PKC inhibition by FB. (1 pM) 
is an order of magnitude lower than the concentration required for 50's 
stimulation by FB. of DMA synthesis (10 pM) , it is likely that PKC is 
implicated in the FB.-elicited signal transduction pathways leading to 
carcinogenesis. At present, it is difficult to evaluate the physiological 
relevance of these findings, because the information on the circulating 
concentrations of FB. in the body is currently unavailable. 
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THRESHOLD DOSE FOR SHORT-TERM CANCER-PROMOTION BY DIETARY FUMONISIN Bi IN 
DIETHYIillTROSAMINE-INITIATED RA.T HEPATOCARCINOGENESIS 
A paper to be sucmitteci to NAT'jRAL TOXINS 
Zhibin Lu, William R. Dantzer, Patricia A. Murphy 5 Suzanne Hendrich 
ABSTRACT 
To establish a short-term threshold dose of fumonisin 3-. (FH;, 
r.epatotoxicity and hepatic f-imor prcmcttcn in rats, female ?34 4/'N rats were 
initiated with 15 mg/k.g diethyinitrosamine at 10 days of age, and were fed 
12.5, 25 and 50 ppm highly purified FBi for 4 weeks after weaning. 
Significant i.ncreases in plasma alani.ne aminotransferase activities by 5 6< 
and 132* were found i.n animals fed 25 and 50 ppm F3-_, respectively. Plasma 
total cholesterol concentrations -were significantly raised by 91* and 145% 
wit.h feedi.ng 25 and 50 ppm TB-., respectively. The rats fed 50 pp.m r"3-. had 
significantly greater hepatic prcstaglanain prcaucticn by 34-611. Placental 
glutat.nione S-transferase PGSTI - a.nd gar.ma-glutamyitransferase ;GGT;-
cositive altered hepatic foci ;.AKr; developed in 25 and 50 ppm FB; groups, 
but .not 12.5 ppm. Feeding 50 ppm FB- significantly increased the percent 
areas of POST- and GGT-positive AKF by aoout 2.1- and 2.5-fold, 
respectively, compared with feeding 25 ppm FB;. Fumonisin 3i, as low as 25 
ppm, was hepatcto.xic a.nd t'umor-promoting in rats. The short-term threshold 
of FB: hepatotoxicity and hepatic tumor pro.motion was probably >12.5 ppm 
and <25 ppm. 
INTRODUCTION 
Fumonisi.n 3-_ 'FB;! is a .Tiycotcxin produced primarily by the corrjr.o.nly 
Fumonisin 3i caused equine ieukoencephalcmalacia (Kellerraan ec ai., 1990; 
Wilson ez al., 1992) and porcine pulmonary edema (Harrison et al., 1990), 
and was hepatotoxic and hepatocarcinogenic in racs (Gelderblom et al., 193 8 
and 1991). The occurrence of FB^ in F. jnoniiiforme-contaminated corn was 
associated with a relatively high rate of human esophageal cancer i.n 
southern .i^frica (Marasas et al., 1988; Sydenham et al., 1990). 
Several biomarkers have been used to study FB. hepatotoxicity and 
hepatic tumor promotion. Fumonisin B-.-promoted rat hepatocarcinogenesis was 
readily quantified by measuring placental glutathione S-transferase (PGST)-
positive altered hepatic foci (A-HF) (Lebepe-Mazur ec al., 1995) and gamma-
glutamyitransferase (GGT)-positive foci (Gelderblom et al,, 1988). Because 
of t.he early occurrence of PGST induction, which was evident within 4 3 h i.n 
single hepatocytes after diethylnitrosamine (DEN) initiation (Moore et al., 
1987), and because of the persistence of both PGST and GGT during 
hepatocarcinogenesis (Hendrich et al., 1937), these two enzymes can serve 
as sensitive biomarkers of early stages of cancer development in the liver. 
Our previous study showed both PGST- and GGT-positive .ojiF were detected 
after 4 weeks in rats fed 50 ppm FBi following DEN initiation (Lu et ai., 
1997). Increased plasma or serum total cholesterol (TC) level and alanine 
aminotransferase (ALT) activity have also been associated with fumonisin 
hepatotoxicity and tumor promotion. Fusarium proliferatum strain 5991-
fermented corn providing 50 ppm FB^ to DEN-initiated rats significantly 
increased plasma TC and ALT while causing hepatocellular adenomas (Hendrich 
et al., 1993). In addition, greater hepatic prostaglandin production was 
related to FB.-promoted hepatocarcinogenesis in rats (Lu et al., 1997). 
Fumonisin Bi has recently been listed as a class 2B carcinogen 
(International Agency for .Research on Cancer, 1993). Development of 
appropriate animal models of carcinogenesis is critical to understanding 
the probable FB-. carcinogenicity in humans. Because nitrosamines often 
contaminate huma.n diets (National .^.cademy of Sciences, 1981), and FB- is 
aimosc. always found in corn-based human foods (Hopmans and Murphy, 1993; 
Sydenham et al., 1991), a 2-stage rodent model combining DEN to initiate 
and FB- to promote carcinogenesis may approach the reality of human 
carcinogenesis (Hendrich et al., 1997). One advantage of utilizing this 
.Tiodel is that the cancer promoting potential of FBi can be readily 
quantified by PGST- and GGT-positive AHF. Our DEN initiation/FBi promotion 
model, i.e. initiation of rats with DEN (15 mg/kg body weight) followed by 
50 ppm FB; promotion for 4 weeks, can induce rat hepatocarcinogenesis 
rapidly, requires relatively small amounts of FB-., and may mimic the 
natural environment where humans are exposed to a combination of chemical 
carcinogens. 
.Although FBi. was non-mutagenic in the Salmonella mutagenicity assay 
(Gelderblom and Snyman, 1991) and lacked genotoxicity based on unscheduled 
DNA synthesis assay in primary rat hepatocytes (Norred et al., 1992), it 
seemed to be a complete carcinogen either at 50 ppm long-term (18-24 
months) or at 250 ppm short-term (3 weeks) (Gelderblom et al., 1991 and 
1994). As a potent promoter in the DEN initiation/FB; promotion model, 
fumonisin B; was effective to promote hepatocarcinogenesis at a dietary 
level of 50 ppm in 4-week studies (Hendrich et al., 1993; Lu et al., 1997). 
It was unknown, however, whether 50 ppm was the cancer-promoting threshold 
dose of FB; short-term. This e.xposure level to FB, may still be greater 
than 10-fold higher than the natural occurrence of FB; in corn-based human 
foods and animal feeds, which commonly contained 0.2-3 ppm FB; (Hopmans and 
Murphy, 1993; Murphy et al., 1993; Sydenham et al., 1991). 
The present study tested our hypothesis that the threshold dose cf 
FB; hepatotoxicity and tumor promotion may be below 50 ppm in the short-
term DEN initiation/FB; promotion model. The dietary FB; levels of 12.5 and 
25 ppm in addition to 50 ppm were selected to approach the natural 
occurrence of FB; in food, to establish dose-response effects of FB; on 
"eEacccGxicicv ar.d hecacocarcir.cger.esis in racs, and tc 3scert2i.n a shcrt-
terni cancsr-promoting threshold for F3-.. 
MATERIALS AND METHODS 
Prepaxation of Piirified Fumonisin Bi 
Tumonisin is a class 23 carcinogen ; International Agency for 
r.esearch on Cancer, 1993) , and standard safety precautions were taken 
auring its handling. 
Liquid cultures of F. prclifaracum strain M5991 were prepared as 
described by Dantzer et al. ;l996a). Fusarmm proliferscum strain M5991, 
which predcminantly produces F3-., was a gift from Dr. Paul Nielsen 
Pennsylvania State University, State College, ?.s) . Fumonisin 3; was 
purified by the sa.Tie procedure as described by Dantter et al. .1995b, . 
Purified TS-_ solutions were freeze-dried, and a dry weight '.vas determi-ied. 
The purified r3; was assayed for r3- as described by Hopma-ns and Murphy 
^1993). The mass of FB- was calculated from the standard curve and compared 
•••'ith t.ie v/eighed mass cf freeze-dried F3-. This ratio was taicen as the 
percent purity cf F3-, 'Dantzer et al., 1996b/ . T.he purity zf the FB-. was 
confirmed to be >95» by Dr. P.cnalc Plattner ;USD.A-.iRS, ;:at:.onal Tenter for 
'.'tilization Research, Peoria, ILy and Dr. Chet Mirocha ;"nLversity ~f 
Minnesota, St. Paul, MM). 
Diets 
.A.11 dietary ingredie.nts e.xcept F3i were obtained from .Harlan Te.k,lad 
Madison, WI) . Four experi.mental diets includi.ng basal diet were fed to 
TFM-i.nitiated rats for 4 weeks. The basal diet supplying 401 of e.nergy as 
rat was rnodiiied from AIN-93G (.American Institute of Mutrition, 19931 . T.he 
-.ngredients of the basal diet were beef tallow 140 g/kg; soybean oil 57 
5/kg; casei.n 224 g/kg; corn starch 228 g/kg; dextrose 224 g/kg; cellulose 
g/kg; vitamin mix ;.AIM-93G-V:<) , 10 g/kg; mineral mix 'Al!;-93G-M;':: , 29 
kg; L-cystine, 3 5/kc; choline bitartrate, 2.5 z/kg; ana T3HC/ 2.114 
JL 
56 
g/kg. Highly purified FB.-containing diets at 3 different FB-. 
concentrations (12.5, 25 and 50 ppm) were prepared by incorporating FB-. 
into the basal diet. All the experimental diets were stored at 4°C before 
use. 
Animals 
The use of animals and the experimental procedure were approved by 
the Iowa State University Animal Care Center Committee. Forty-eight 10-day-
old female F344/N rats obtained from Harlan Sprague-Dawley (Madison, WI) 
were injected intraperitoneally with DEN (15 mg/kg body weight) in 0.1 mL 
of corn oil. .^t 3 weeks of age, the weaned rats were randomly assigned to 
one of the 4 treatment groups with 12 rats each. The rats were given free 
access to the experimental diets and water for 4 weeks in an animal 
facility with a 12-h light/dark cycle maintained at 22-25°C and 50% 
humidity. Body weight and feed intake of the rats were recorded weekly. 
Plasma and Liver Sample Preparation 
Part of the plasma obtained from heparinized blood was analyzed 
within 24 h for ALT activity. The remaining plasma was stored at -80°C and 
later analyzed for plasma TC concentration. 
The liver was excised and each of the three largest lobes of the 
liver was sliced into 1 cm slices. Three slices, one from each lobe, were 
immediately frozen as a block on dry ice and stored at -80°C. From each of 
the frozen liver blocks, two 10-pm serial sections were cut with a 
Histostat Microtome (Model 855, Leica Inc., Deerfield, IL) for later 
staining for GGT and PGST. 
From each rat, 0.5 g of minced liver portions was immediately 
homogenized in an ice bath with 10 passes of a Potter-Elvehjem homogenizer 
in 5 ml, pH 7.4, 50 mM potassium phosphate buffer containing 4.2 mM 
acetylsalicylic acid. The liver homogenates were frozen on dry ice and 
stored at -80°C for later analyses of endogenous hepatic PGF;, and PGE; 
Plasma Total Cholesterol Concentration and Alanine Aminotransferase 
Activity 
Plasma TC concentration was determined by using Sigma diagnostic kit, 
procedure 352-3 (Sigma Chemical Co., St. Louis, MO). Plasma ALT activity 
was measured by using Sigma diagnostic kit for the glutamate/pyruvate 
transaminase optimized .AiT assay (Sigma Chemical Co., St. Louis, MO). 
Staining and Quantification of Altered Hepatic Foci 
One of the frozen serial sections was stained for the presence of 
?GST-positive AHF. Placental glutathione S-transferase was detected by 
using a Vectastain ABC Elite anti-rabbit IgG kit (Vector Laboratories, 
3urlingame, CA). Placental glutathione S-transferase was purified by the 
method of Sato et al. (19S4), and rabbit anti-rat PGST antiserum was 
prepared as described by Hendrich and Pitot (1987) . 
The second frozen serial section was stained for GGT activity as 
described by Rutenburg et al. (1968). The substrate for GGT was gamma-
glutamyl-4-naphthylamide (GMNA) (United States Biochemical Corp., 
Cleveland, OH). 
Altered hepatic foci were quantified via computer-assisted image 
analysis. I.mages of the serial sections stained for PGST and GGT were taken 
by a Sony 3-chip color video camera DXC-3000A, digitally transferred from 
the camera to a SiliconGraphics Indigo 2 XZ computer work station 
•SiliconGraphics, Mountain View, CA), and analyzed with Visilog image 
analysis software (Version 5.0.2, Noesis, St. Laurent, Quebec, Canada). The 
images were broken down to red, blue and green colors, followed by contrast 
enhancement. The whole tissue was outlined to obtain its total area after 
erosion was processed to delete any edge effect (artifactual darkening 
around the tissue edge as a result of staining procedure). A threshold of 
pixel values was selected for the lesions, so that only lesions were 
counted for calculation of lesion area. Calibration for the image analysis 
v/as accurate to mm. 
Radioimmunoassay for Hepatic Prostaglandin F2«: and £2 Levels 
Endogenous liver PGF;^ and PGE; levels were determined by 
radioimmunoassay according to the method of McCosh et al. (1976) . Anti-rat 
PGF;^ rabbit antiserum was purchased from Sigma Chemical Co., St. Louis, 
MO. Anti-rat PGE: rabbit antiserum was a gift from Dr. Jaqueline Dupont, 
USDA-.ARS, Beltsville, MD. Goat anti-rabbit gamma globulin was obtained from 
Western Chemical Research Corp., Fort Collins, CO. Concentrated [-H]PGF;i 
and ['H]PGE: with specific activities of 168.0 and 154.0 Ci/mmol, 
respectively, were purchased from Dupont New England Nuclear, Boston, MA. 
Standards of PGF;^ and PGE; were obtained from Sigma Chemical Co., St. 
Louis, MO. Scintiverse BD (Fisher Chemical, Fair Lawn, NJ) was added to 
each tube before counting. Sample-containing tubes were run in duplicate. 
Total count tubes and background tubes were counted in triplicate. Si.'< 
replicates were made to determine total binding. .Along with the samples, a 
standard curve was run in duplicate, one set at beginning of the sample run 
and the other set at the end. Radioactivity was determined as cpm by using 
a Packard liquid scintillation analyzer model 1900 TR (Packard Instrument 
Co., Downers Grove, IL). 
Statistical Analysis 
The hepatic PGF:^ and PGE; concentrations were determined by a 
computer program based on a logit transformation of the standard curve 
(Duddleson et al., 1972). General Linear Models procedure (GLM) was 
performed on feed consumption, body weight, liver to body weight ratio, 
plasma TC level and ALT activity, and hepatic concentrations of PGF:^ and 
PGE;, using the Statistical Analysis System (SAS, Release 6.06, Cary, NC) . 
Contrasts were done to compare treatment differences. For the analysis of 
percent volume of PGST- and GGT-positive AHF, Student's c-test was 
performed to compare the groups showing lesions. Treatment differences were 
considered significant at P<0.05. 
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RESULTS 
Mean daily feed intake among the groups of rats were the same for all 
groups (Table 1). Overall mean daily feed intake was approximately 10 g. 
Fumonisin Bi caused a significant reduction in final body weight. A weight 
reduction by 15% was fcund in the rats fed 50 ppm FBi. (P<0.01), and a 
weight reduction in the rats fed 25 ppm FB; was significant (P<0.05). In 
addition, feeding 50 ppm FB, significantly decreased body weight by 9% as 
compared with feeding 25 ppm FBi (P<0.01). Fumonisin 3-, at 12.5 ppm did not 
e.xert a toxic effect on body weight (Table 1) . The liver weight to body 
weight ratio was significantly increased by 11% as a result of 50 ppm FB-
feeding (P<0.01) . Feeding 50 ppm FBi significantly increased the liver 
weight to body weight ratio by 9'! compared with feeding 25 ppm FB; 
(P<0.01). Nei-her 25 nor 12.5 ppm FB; feeding had a significant effect on 
the ratio as compared with that of the control feeding (Table 1). 
Significant increases in plasma ALT activity compared to control rats 
by 861 and 132% were found in the animals fed 25 and 50 ppm FB;, 
respectively (P<0.011. There was no significant difference in the plasma 
ALT activity between the group fed 12.5 ppm FB; and the control group. The 
25% difference in the plasma ALT activity between the rats fed 50 ppm FB; 
and those fed 25 ppm FB; was not significant (Table 2) . 
Fumonisin B; had a dose-dependent effect on plasma TC concentration. 
Feeding 25 and 50 ppm FB; significantly raised the plasma TC by 91% and 
145%, respectively, over the control group (P<0.01). The plasma TC level 
was elevated significantly by 28% with the increasing FB; concentrations 
from 25 ppm to 50 ppm (P<0.05) (Table 2). 
Compared with the control rats, the animals fed 50 ppm FB; had 
significantly greater hepatic PGF;, and PGE; concentrations by 61% and 34%, 
respectively (P<0.05). No significant difference from the control group was 
found in prostaglandin production in the other two groups (Table 2). 
60 
All of the rats fed 50 ppm FBi developed both PGST- and GGT-positive 
AHF, which also appeared in 11 of 12 rats fed 25 ppm FB-.. In addition, 
feeding 50 ppm FB. significantly increased the percent areas of PGST- and 
GGT-positive AHF, expressed as the percentage of the area occupied by PGST-
or GGT-positive AHF over the total area of the liver section, by about 2.1-
and 2.5-fold, respectively, compared with feeding 25 ppm FB-, (P<0.05). 
There v/ere no PGST- or GGT-positive AHF in either the 12.5 ppm FBi group or 
the control group (Table 3). More and larger GGT-positive AHF with sharper 
edge developed in livers of rats fed 50 ppm FB,. than those i.n livers of 
rats fed 25 ppm FB., and no GGT-positive AJiF developed in the group fed 
12.5 ppm FB-. (Figure 1). 
DISCUSSION 
This study demonstrated that FB-. was able to exert hepatotoxic and 
tumor-promoting effects at as low as 25 ppm in a short-term DEN 
initiation/FBi promotion rodent model, and greater effects were produced by 
feeding 50 ppm FB^ than by feeding 25 ppm FBi. to rats during the promotion 
phase. The dose-dependent FB; toxicity and tumor promotion were reflected 
in reduced body weight, increased liver weight to body weight ratio, 
elevated plasma TC concentration and ALT activity, increased hepatic 
prostaglandin production, and development of PGST- and GGT-positive AHF. 
Fumonisin B- caused significant reduction in final body weight, 
apparently without affecting feed intake (Table 1) . The toxic FB; doses 
would approximate 2.5-5 mg FB-Vkg body weight per day. The body weight and 
feed intake data were in agreement with our results reported previously 
(Hendrich et al., 1993; Lu et al., 1997), but not with those of two other 
studies using different animal models. Bondy et al. (1995) reported that 
both body weight and feed consumption of Sprague-Dawley rats were 
significantly decreased within 4 days, with daily intraperitoneal injection 
of 7.5 or 10 mg FB;/kg body weight. Voss et al. (1995) demonstrated that 
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neither body weight nor feed intake was significantly decreased in F344 
rats fed 1, 3, 9, 27 and 81 ppm FB, for 90 days. The reduction in feed 
intake in the 4-day study may be temporary because it was reported that FB 
at dietary levels of 250, 500 and 750 ppm induced feed refusal in rats 
during the first days of a 21-day study, but the feed intake of the FB..-
treated rats was increased after 14 days and reached control level by 21 
days (Gelderblom et al., 1994). The lack of toxic effect of FBr on body 
weight in the 90-day feeding study may be explained by the fact that 
hepatotoxicity and hepatocarcinogenesis were not found in the rats fed up 
to 31 ppm FB',. 
The dose-dependent increase in the relative liver weight, expressed 
as the liver weight to body weight ratio, was not only a sign of FB-
hepatotoxicity, but was related to tumor promotion by FB; as well, because 
the group with the largest relative liver weight had the most PGST- and 
GGT-positive AHF (Tables 2 and 3). This relative hepatomegaly has been 
observed in other studies using FB, as a tumor promoter (Hendrich et ai., 
1993; Lebepe-Mazur et al., 1995). 
Plasma .AiT activity, plasma TC concentration and hepatic 
prostaglandin production were also associated with both the toxicity and 
the tumor-promoting ability of FBi in the present study. Fumonisin B; 
e.xerted dose-dependent effects on the increases in the concentrations or 
the activity of these biomarkers, with the greatest effects in the group 
(50 ppm FBi) showing relatively most advanced tumor promotion which was 
represented by the greatest percent areas of PGST- and GGT-positive .^HF 
(Tables 2 and 3). The alterations of these biomarkers, therefore, were 
closely related to t.he FBi-promoted hepatocarcinogenesis in addition to 
hepatotoxicity. 
This study supported previous findings that elevated plasma ALT 
activity and cholesterol concentration in FB,-treated rats were associated 
with hepatotoxicity (Bondy et al., 1996; Voss et al., 1993), and 
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hepatocarcinogenesis as well (Hendrich et al., 1993; Li; et al., 1997; . 
Increased plasma ALT activity generally indicates release of this enzyme 
from damaged hepatocytes with altered plasma membrane permeability. 
Exposure of hepatocytes to hepatotoxicants is likely to cause oxidative 
stress, which in turn may induce plasma membrane damage (Halliwell, 1994). 
Fumonisin B-., as a hepatotoxicant, could subject hepatocytes to increased 
lipid peroxidation, based on a reported accumulation of polyunsaturated 
fatty acids in primary hepatocytes treated with 150 and 500 (iM FB; 
(Gelderblom et al., 1996). 
The mechanism underlying the effect of FB-, on plasma total 
cholesterol is unknown. The increase in plasma TC might result from 
stimulated cholesterol synthesis in hepatocytes, or impaired cholesterol 
removal by the liver. Indirect evidence supports both viewpoints. Activity 
of 3-hydroxy-3-methylglutaryl CoA (.4MG CoA) reductase, a rate-limiting 
enzyme of cholesterol biosynthesis, was 2-fold greater in primary 
hepatocellular carcinomas induced by feeding 0.04% 2-acetylaminofluorene 
for 20 weeks than in normal livers from rats {Mitchell et al., 1978). Maybe 
HMG CoA reductase activity can be stimulated during FBi-promoted 
hepatocarcinogenesis as well. Based on elevation of plasma LDL, but not HDL 
or VLDL, and lack of accumulation of cholesterol in livers of vervet 
monkeys fed a low fat diet containing fumonisins, it was proposed that the 
removal of cholesterol from plasma via hepatic LDL receptor could be 
impaired (Fincham et al., 1992). The increase in plasma TC seemed to be 
secondary to FBi hepatotoxic and tumor-promoting effects. Whether 
cholesterol-lowering agents can counteract the effects of FB,. has not been 
investigated. 
Changes in hepatic prostaglandin production mirrored those observed 
in our previous study showing greater hepatic concentrations of PGF;, and 
?GE; in rats fed 50 ppm FBi than in rats fed basal diet (Lu et al., 1997). 
Our data suggested that the elevation of prostaglandin levels paralleled 
the induction of PGST- and GGT-positive AHF, but prostaglandin status was 
extremely variable among individuals, making this biomarker less sensitive 
than the other biomarkers studied. Increased prostaglandin production may 
have been caused by hepatocarcinogenesis promoted by FBi. Similar to plasma 
TC, the increase in prostaglandin production was also likely to be 
secondary to hepatotoxicity and hepatocarcinogenesis. Prostaglandins may 
contribute to cell proliferation in the liver at certain stages during FB-. 
treatment. Increased prostaglandin concentrations were associated with 
preneoplastic cell proliferation (Delescluse et al., 1982). Inhibition of 
prostaglandin synthesis by indomethacin played a role in suppressing tumor 
growth in vivo and prolonging survival time of hepatoma-bearing rats by 
approximately 50% (Trevisani et al., 1980). The possible suppressive effect 
of prostaglandin synthesis inhibitors on FB: tumor promotion has yet to be 
studied. 
Placental glutathione S-transferase and GGT are markers of AHF 
{Goldsworthy and Pitot, 1985; Sato et al., 1984). These enzymes effectively 
scored many types of chemical hepatocarcinogenesis (Hendrich et al., 1987). 
The development of GGT- and/or PGST-positive AHF was also demonstrated in 
FB-.-induced hepatocarcinogenesis (Gelderblom et al., 1988; Lebepe-Mazur et 
al., 1995; Lu et al., 1997). In the present study all the rats fed 50 ppm 
FB; developed both PGST- and GGT-positive .AHF, which also appeared in 11 of 
12 rats fed 25 ppm FBi. The dose-dependent increase in the percent areas of 
PGST- and GGT-positive AHF suggested that the promotion in the rats fed 25 
ppm FB; was not as advanced as in the ones fed 50 ppm FBi, although at both 
concentrations, the carcinogenesis was still at early stages as indicated 
by PGST- and GGT-positive .AHF, which were preneoplastic lesions. 
This study confirmed our previous finding that feeding 50 ppm FB; 
for 4 weeks elicited hepatotoxicity and tumor promotion in DEN-initiated 
rats (Hendrich et al., 1993; Lu et al., 1997). The consistency of the 
results indicated that our short-term DEN initiation/FB; promotion model 
was proficient in quantifying FBi-promoted carcinogenesis. This model was 
adapted from Peraino's (Peraino et al., 1984), in which effects of tumor 
promoters generally can be detected at 3 months after weaning. However, 
tumor promotion by FBi at 25 and 50 ppm can be detected at only 1 month 
after weaning. The rapidity of FBi tumor promotion in this model might 
facilitate studies of FB; promotion mechanisms and inhibitors of FB; 
pro.T.otion. This model may also be used to screen potential tumor promoters 
in a relatively short period of time. The relevance of this model to human 
carcinogenesis may be attributed to the combination of 2 carcinogens, DEN 
and FBi, which commonly contaminate human foods in appreciable amounts. The 
combination of a tumor initiator and a tumor promoter in the bioassay may 
serve as a simplified model of the natural environment in which humans are 
often exposed to multiple carcinogens. The presence of FB-. and nitrosamines 
in human foods raises a possibility that populations in high risk areas of 
human esophageal cancer are e.xposed to both carcinogens co.ncomitantly. 
The present study e.xtended our previous finding to a lower dose of 
FBi, i.e. feeding 25 ppm FB, for 4 weeks elicited hepatotoxicity and tumor 
promotion in DEN-initiated rats. Fumonisin B-. at 12.5 ppm, .however, was 
unable to produce any adverse effects as evidenced by lack of significant 
changes in plasma TC concentration, plasma AiT activity and hepatic 
prostaglandin production, and by complete absence of PGST- and GGT-positive 
A.HF (Table 3). Therefore, using the short-term DEN initiation/FBi promotion 
model, an approximate short-term threshold dose of FB; was determined. 
.^.Ithough it was impossible to ascertain its exact value, the threshold, at 
which FBi should evoke an all-or-none response, was very probably >12.5 ppm 
but <25 ppm. The threshold dose of FBi obtained in this study was well 
within the range of fumonisin concentrations associated with a relatively 
high risk of human esophageal cancer (3-47 ppm, Sydenham et al., 1991) and 
field outbreaks of animal diseases (<1-330 ppm, Ross et al., 1990), and 
this threshold dose was approximately an order of magnitude greater than 
Che FB; levels found in corn-based human foods and animal feeds (0.2-3 
ppm) . 
Using different animal models, some investigators have reported 
various minimum doses required for FB.. to produce toxic and carcinogenic 
effects. Feeding 1000 ppm FBi to DEN (200 mg/kg body weight)-initiated rats 
for 4 weeks induced GGT-positive foci in the liver (Gelderblom et al., 
1988). When corn cultures of F. proliferacum providing 20 ppm FBi. were fed 
zo DEN (30 mg/kg body weight)-initiated rats for 6 months, induction of 
PGST-positive AHF was exhibited (Lebepe-Mazur et al., 1995). Rats fed 50 
ppm FB- for 18-26 months developed primary hepatocellular carcinoma and 
cholangiocarcinoma (Gelderblom et al., 1991). The lowest dietary dose of 
FB; required for cancer initiation in the rat liver over 21 days was 250 
ppm (Gelderblom et al., 1994). Therefore, longer-term exposure seemed to 
lower FB-_'s minimum to.xic dose. Apart from the liver, the kidney was also a 
target organ of fumonisin toxicity in rats. Voss et al. (1993) reported 
that FB; was hepatotoxic to rats fed 150 ppm for 4 weeks and was 
nephrotoxic at 15-50 ppm. In a subchronic feeding study, hepatotoxicity was 
not found in rats fed up to 31 ppm FB; for 90 days, but nephrotoxicity 
occurred at 9-81 ppm (Voss et al., 1995). Comparing the studies of Voss et 
al. (1993 and 1995) with their own 28-day feeding study on fumonisin 
hepato- and nephroto.xicity in rats, Tolleson et al. (1996) estimated that 
the lowest hepatotoxic and the lowest nephrotoxic doses of FB; in rats were 
99-250 ppm and 9-100 ppm, respectively. Taken together, with respect to FB; 
hepatotoxicity and hepatocarcinogenicity, the threshold of FB; determined 
in our present study was apparently among the lowest. 
CONCLUSION 
This study demonstrated that feeding 25 ppm FB; for 4 weeks induced 
tumor promotion in DEN-initiated rats. Different threshold doses of FB-, 
however, probably exist, depending on the selection of animal models. Based 
an Che results from the other studies discussed above, a longer-term 
feeding could further lower the threshold of FB: in a DEN initiation/FB. 
promotion model, thus approaching more closely the naturally occurring dose 
of FB1, 
It is noticeable that esophageal cancer occurring in humans has not 
been experimentally reproduced with FB.. in any animal models, and there has 
been no evidence associating FBi. with human hepatocarcinogenesis. Moreover, 
information on the mechanisms underlying the species- and organ-specificity 
of toxic and/or carcinogenic effects of FB- is currently very limited. 
Future studies are greatly needed to understand the mechanisms of fumonisin 
toxicity and carcinogenicity, to determine whether there is a causative 
relationship between fumonisins and human esophageal cancer, and to 
establish tolerance levels for fumonisins in corn-based human foods and 
animal feeds. 
REFERENCES 
American Institute of Nutrition (1993) AIN-purified diets for laboratory 
rodents: final report of the American Institute of Nutrition Ad Hoc writing 
committee on the reformulation of the AIN-76A. rodent diet. J. Nutr. 123: 
1939-1951. 
Bondy, G., Suzuki, C., Barker, M., Armstrong, C, Fernie, S., Hierlihy, L., 
Rowsell, P. & Mueller, R. (1995) Toxicity of fumonisin B-. administered 
intraperitoneally to male Sprague-Dawley rats. Food Chem. Toxicol. 33: 653-
665. 
Bondy, G., Barker, M., Mueller, R., Fernie, S., Miller, J. D., .Armstrong, 
C., Hierlihy, S. L., Rowsell, P. & Suzuki, C. (1996) F'omonisin Bi toxicity 
in .male Sprague-Dawley rats. In Jackson, L. S., DeVries, J. W. & Bullerman, 
L. B. (eds): "Fumonisins in Food", New York: Plenum Press, pp 251-264. 
Campbell, H. A., Xu, Y., Hanigan, M. H. & Pitot, H. C. (1986) Application 
of quantitative stereology to the evaluation of phenotypically 
heterogeneous enzyme-altered foci in rat liver. JNCI 76: 751-765. 
Dantzer, W. R., Pometto, A. L. & Murphy, P. .A. (1996a) Fumonisin B^ 
production by Fusarium proliferatum strain M5991 in a modified Myro liquid 
medium. Nat. Toxins 4: 168-173. 
Dantzer, W. R., Hopmans, E. C., Clark, .A., Hauck, C. C. & Murphy, P. .A. 
(1996b) Purification of fumonisin Bi from liquid cultures of Fusarium 
proliferatum in a modified Myro medium. J. .Agric. Food Chem. 44 : 3730-3732. 
Deiescluse, C. G., rurstenburger, F., Marks, F. & Prunieras, M. (1982} 
Effects of phorbal esters on basal epidermal cells from adult guinea pig 
ear skin. Cancer Res. 42: 1975-1979. 
Duddleson, W. G., Midgley, A. R. Jr. & Niswender, G. D, (1972) Computer 
program sequence for analysis and summary of radioimmunoassay data. Comput. 
Biomed. Res. 5: 205-217. 
Fincham, J. E., Marasas, W. F. O., Taljaard, J. J. F., Kriek, N. P. J. 
Badenhorst, C. J., Gelderblom, W. C. A., Seier, J. V., Smuts, C. M., Faber, 
M., Weight, M. J., Slazus, W., Woodroof, C. W., van Wyk, M. J., Kruger, M. 
& Thiel, P. G. (1992) Atherogenic effects in a non-human primate of 
Fusarium maniliforme cultures added to a carbohydrate diet. Atherosclerosis 
94: 13-25. 
Gelderblom, W. C. .A., Jaskiewicz, K., Marasas, W. F. O., Thiel, P. G., 
Horak, R. M., Vleggaar, R. & Kriek, N. P. J. (1988) Fumonisins—novel 
mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. 
Appl. Environ. Microbiol. 54: 1806-1811. 
Gelderblom, W. C. A., Kriek, N. P. J., Marasas, W. F. 0. & Thiel, P. G. 
(1991) To.xicity and carcinogenicity of the Fusarium moniliforme metabolite, 
fumonisin B-,, in rats. Carcinogenesis 12: 1247-1251. 
Gelderblom, W. C. A. & Snyman, S. D. (1991) Mutagenicity of potentially 
carcinogenic mycotoxins produced by Fusarium moniliforme. Mycotoxin Res. 7: 
46-52. 
Gelderblom, W. C. .A., Cawood, M. E., Snyman, S. D. & Marasas, W. F. 0. 
(1994) Fumonisin Bi dosimetry in relation to cancer initiation in rat 
liver. Carcinogenesis 15: 209-214. 
Gelderblom, W. C. .A., Smuts, C. M. , .^el, S., Snyman, S. D., Cawood, M. E, 
van der Westhuizen, L. & Swanevelder, S. (1996) Effect of fumonisin Bi on 
crotein and lipid synthesis in primary rat hepatocytes. Food Chem. To.xicol. 
34: 361-369. 
Goldsworthy, T. L. & Pitot, H. C. (1985) The quantitative analysis and 
stability of histochemical markers of altered hepatic foci in the rat liver 
following initiation by diethylnitrosamine administration and promotion 
with phenobarbital. Carcinogenesis 6: 1261-1269. 
Halliwell, B. (1994) Free radicals, antioxidants, and human disease: 
curiosity, cause, or consequence. The Lancet 344: 721-724. 
Harrison, L. R., Colvin, B. M., Greene, J. T., Newman, L. E. & Cole, J. R. 
(1990) Pulmonary edema and hydrothorax in swine produced by fumonisin B-., a 
toxic metabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 2: 217-
221. 
Hendrich, S., Campbell, H. A. & Pitot, H. C. (1987) Quantitative 
stereological analysis of four histochemical markers of altered foci in 
multistage hepatocarcinogenesis in the rat. Carcinogenesis 8: 1245-1250. 
Hendrich, S. & Pitot, H. C. (1987) Enzymes of glutathione metabolism as 
biochemical markers during heoatocarcinogenesis. Cancer Metastasis Rev. 
155-178. 
63 
Hendrich, S., Miller, K., A., Wilson, T. M. & Murphy, P. A. (1993) Toxicity 
of Fusarium proliferacum-fermented nixtamaiized corn-based diets fed to 
rats: effect of nutritional status. J. Agric. Food Chem. 41: 1649-1654. 
Hendrich, S., Lu, Z., Wang, H.-J., Hopmans, E. C. & Murphy, P. A. (1997) 
Soy isoflavone extract suppresses fumonisin Bi-promoted rat 
hepatocarcinogenesis. Am. J. Clin. Nutr. in press 
Hopmans, E. C. & Murphy, P. A. (1993) Detection of fumonisins Bi, B; and B-. 
and hydrolyzed fumonisin B. in corn-containing foods. J. Agric. Food Chem. 
41: 1655-1658. 
International Agency for Research on Cancer (1993) Toxins derived from 
Fusarium moniliforme: Fumonisins Bt, B; and Fusarin C. 56: 445-466. 
Kellerman, T. S., Marasas, W. F. 0., Thiel, P. G., Gelderblom, W. C. A., 
Cawood, M. E., & Coetzer, J. .A. W. (1990) Leukoencephalomalacia in two 
horses induced by oral dosing of fumonisin Bi. Onderstepoort J. Vet. Res. 
57: 269-275. 
Lebepe-Mazur, S., Wilson, T. & Hendrich, S. (1995) Fusarium proliferacum-
fermented corn stimulates development of placental glutathione S-
transferase-positive altered hepatic foci in female rats. Vet. Human 
Toxicol. 37: 55-59. 
Lu, Z., Dantzer, W. R., Hopmans, E. C., Prisk, V., Cunnick, J. E., Murphy, 
P. A. & Hendrich, S. (1997) Reaction with fructose detoxifies fumonisin B-. 
while stimulating liver-associated natural killer cell activity in rats. J. 
.Agric. Food Chem. 45: 803-809. 
Marasas, W. F. 0., Jaskiewicz, K., Vender, F. S. & Van Schalkwyk, D. J. 
(1988) Fusarium moniliforme contamination of maize in esophageal cancer 
areas in Transkei. S. .^fr. Med. J. 74: 110-114. 
McCosh, E. J., Meyer, D. L., Dupont, J. (1976) Radioimmunoassay of 
prostaglandins E., E; and F;, in unextracted plasma, serum, and myocardium. 
Prostaglandins 12: 471-486. 
Mitchell, A. D., Pugh, T. D. & Goldfarb, S. (1978) Partial "feedback 
control" of beta-hydroxy-beta-miethylglutaryl coenzyme A reductase activity 
in primary hepatocellular carcinomas. Cancer Res. 38: 4474-4477. 
Moore, M. A., Nakagawa, K., Satoh, K., Ishikawa, T. & Sato, K. (1987) Short 
communications: single GST-P positive liver cells—putative initiated 
hepatocytes. Carcinogenesis 8: 483-486. 
Murphy, P. A., Rice, L. G. & Ross, P. F. (1993) Fumonisin B,, B: and B^ 
content of Iowa, Wisconsin, and Illinois corn and corn screenings. J. 
•Agric. Food Chem. 41: 263-266. 
National Academy of Sciences (1981) The Health Effects of Nitrate, Nitrite, 
and N-Nitroso Compounds. National Academy Press, Washington, D. C. 
Norred, W. P., Plattner, R. D., Vesonder, R. F., Bacon, C. W. & Voss, K. A. 
(1992) Effects of selected secondary metabolites of Fusarium moniliforme on 
unscheduled synthesis of DNA by primary rat hepatocytes. Food Chem. 
Toxicol. 30: 233-237. 
69 
Peraino, C., Scaffeldt, E. F., Carnes, B. A., Ludeman, V. A., Blomquisc, J. 
A. & Vesselinovitch, S. D. (1984) Characterization of histochemically 
detectable altered hepatocyte foci and their relationship to hepatic 
tumorigenesis in rats treated once with diethylnitrosamine or 
benzo(a)pyrene within one day after birth. Cancer Res. 44: 3340-3347. 
Rutenburg, A. M., Kim, H., Fischbein, J. W., Hanker, J. S., Wasserhrug, H. 
L. & Seligman, A. M. (1968) Histochemical and ultrastructural demonstration 
of gamma-glutamyl transpeptidase activity. J. Histochem. Cytochem. 17: 519-
526. 
Ross, P. F., Rice, L. G., Plattner, R. D., Osweiler, G. D., Wilson, T. M., 
Owens, D. L., Nelson, H. A. & Richard, J. L. (1991) Concentrations of 
f'-imonisin Bi in feeds associated with animal health problems. 
Mycopat.hologia 114 : 129-135. 
Sato, K., Kitahara, .A., Satoh, K., Ishikawa, T., Tatematsu, M. & Ito, N. 
(1984) The placental form of glutathione S-transferase as a .new marker 
orotein for preneoplasia in rat chemical hepatocarcinogenesis. Gann 75: 
199-202. 
Sydenham, E. W., Thiel, P. G., Marasas, W. F. 0., Shephard, G. S., Van 
Schalkwyk, D. J. & Koch, K. R. (1990) Natural occurrence of some Fusarium 
moniliforme mycotoxins in corn from low and high esophageal cancer 
prevalence area of the Transkei, Southern Africa. J. Agric. Food Chem. 38: 
1900-1903. 
Syndenham, E. W., Gelderblom, W. C. A., Thiel, P. G., Marasas, W. F. 0. & 
Stockenstrom, S. (1991) Fumonisin contamination of commercial corn-based 
human foodstuffs. J. Agric. Food Chem. 39: 2014-2018. 
Tollescn, W. H., Dooley, K. L., Sheldon, W. G., Thurma.n, J. D., Bucci, T. 
J. & Howard, P. C. (1996) The mycotoxin fumonisin induces apoptosis in 
cultured human cells and in livers and kidneys of rats. In Jackson, L. S., 
DeVries, J. W. & Bullerman, L. B. (eds): "Fumonisins in Food", New York: 
Plenum Press, pp 251-264. 
Trevisani, A., Ferretti, E., Cappuzo, A. & Tomasi, V. (1980) Elevated 
levels of prostaglandin E; in Yoshida hepatoma and the inhibition of tumor 
growth by non-steroidal anti-inflammatory drugs. Br. J. Cancer 41: 341-347. 
Voss, K. A., Chamberlain, W. J., Bacon, C. VJ. & Norred, W. P. (1993) .A 
preliminary investigation on renal and hepatic toxicity in rats fed 
purified fumonisin Bi. Nat. Toxins 1: 222-228. 
Voss, K. A., Chamberlain, W. J., Bacon, C. W., Herbert, R. A., Walters, D. 
B. & Norred, W. P. (1995) Subchronic feeding study of the mycotoxin 
fumonisin Bi in B6C3F1 mice and Fischer 344 rats. Fund. Appl. Toxicol. 24: 
102-110. 
Wilson, T. M., Ross, P. F., Owens, D. L., Rice, L. G., Green, S. 
A., Jenkins, S. J. & Nelson, H. A. (1992) E.xperimental reproduction of ELEM: 
a study to determine minimum toxic dose in ponies. Mycopathologia 117: 115-
1 2 0 .  
70 
Table 1. Fumonisln Bi (FBi) Decreased Body Weight and Increased Liver 
Weight to Body Weight Ratio (LW/BW Ratio) , but Did Not Affect Feed Intake* 
Body Weight(g) LW/BW(xlO--) Feed Intake(g/d) 
Control 
12.5 ppm FB'_ 
25 ppm FBt 
50 ppm FB-_ 
119 ± 9 
112 ± 10 
1 1 0  ±  7 ^  
100 ± 9°" 
4.4 ± 0.3 
4.2 ± 0.2 
4.5 ± 0.5 
4.9 ± O.S^ '^  
10  ±  1  
10  ±  2  
10  ±  2  
10  ±  2  
The values are given as group means ± standard deviations, n=12. 
^Significantly different from the control group, P<0.05. 
"Significantly different from the control group, P<0.01. 
"Significantly different from the 25 ppm FBi group, P<0.01. 
Table 2. Fumonisin Bx (FBx) Incxeased Plasma Total Cholesterol (TC) 
Concentration, Plasma Alanine Aminotransferase (ALT) Activity, and Hepatic 
Prostaglandin (PG) Production 
Plasma TC Plasma ALT Hepatic PGF. 
.X Hepatic PGE: 
(mg/dL) act. (u/L) (ng/g) (ng/g) 
Concrol 89 ± 15 28 ± 4 59 ± 34 50 ± 16 
12.5 ppm FB; 103 ± 28 27 ± 6 61 i 47 56 ± 26 
25 ppm FBi 170 ± 52' 52 ± 25a 85 ± 50 60 ± 23 
5 0 ppm FB. 218 ± 73'''' 65 ± 24^ 95 ± 48° 68 ± 19"^ 
'The values are given as group means ± standard deviations , n=12. 
'Significantly different from the control group. P<0 .01. 
"Significantly different from the control group. P<0 .05. 
-'Significantly different from the 25 ppm FBi group, P<0.05. 
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Table 3. Placental Glutathione S-Transferase (PGST)-Positive (PGST*) amd 
Gaiama Glutamyl transferase (GGT) -Positive (GGT*) Altered Hepatic Foci (AHF) 
Occurred in Rats Fed 25 and 50 ppm Fumonisin Bx (FBi) , and the Percent 
Areas of PGST'^ and GGT"^ AHF (% PGST Area and % GGT Area) Increased with the 
Higher FBi Level* 
# of Rats with % PGST Axea # of Rats with % GGT Area 
PGST* AHF GGT' AHF 
Control 0 0 0 0 
12.5 ppm F3i 0 0 0 0 
25 ppm FB; 11 12 ± 13 11 6 ± 5 
50 ppm FB; 12 24 ± 16^ 12 14 ± 8^ 
'The percent areas of PGST" and GGT* AHF are expressed as the percentage of 
the area occupied by PGST" or GGT* AHF over the total area of the liver 
section. The values are given as group means ± standard deviations, n=12. 
'Significantly different from the 25 ppm FBi. group, ?<0.05. 
Figure 1. More and larger gamma-glutamyltransferase-positive altered 
hepatic foci with sharper edge developed in livers of rats fed 50 ppm FBi 
(FBl-50) than those in livers of rats fed 25 ppm FBi (FBl-25) , and no 
gamma-glutamyl transferase-positive altered hepatic foci occurred in the 
12.5 ppm FBi (FBl-12.5) group. 
F B l - 1 2 .  F B l - 2 5  
A 
FBl-50 
REACTION WITH FRUCTOSE DETOXIFIES FUMONISIN Bi WHILE STIMULATING LIVER-
ASSOCIATED NATURAL KILLER CELL ACTIVITY IN RATS 
A paper published in che Journal of Agricultural and Food Chemistry 
Z. Lu", W. R. Dantzer", E. C. Hopmans*, V. Prisk", J. E. Cunnick", P. A.. 
Murphy^, S. Hendrich"' 
ABSTRACT 
Fumonisin Bi (FB-J was reacted with fructose in an attempt to 
detoxify this mycotoxin. Fischer 344/N rats were initiated with 
diethylnitrosamine (15 mg/kg body weight) and then fed 69.3 pmol FB-./kg 
diet or 69.3 pmol FBt reacted with fructose (FB;-fructose)/kg diet for 4 
weeks. In comparison with the rats fed basal diet or FBi-fructose, the FB--
fed rats had significantly increased plasma cholesterol (P<0.01), plasma 
alanine aminotransferase activity (P<0.05), and endogenous hepatic 
prostaglandin production (P<0.05). Placental glutathione S-transferase-
positive and yglutamyltransferase-positive altered hepatic foci occurred 
only in the FBi-fed rats. Liver-associated natural killer (NK) cell 
activity was significantly decreased in the FBi.-fed rats, and increased in 
the group fed FBi-fructose, as compared with the basal group (P<0.03) . 
Therefore, modifying FB-, with fructose seems to prevent FBi.-induced 
hepatotoxicity and promotion of hepatocarcinogenesis while stimulating 
liver-associated NK cell activity in rats. 
•Department of Food Science and Human Nutrition, Iowa State University. 
-Department of Microbiology, Immunology and Preventive Medicine, Iowa State 
University. 
'Author to whom correspondence should be addressed 
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INTRODUCTION 
Fumonisin B: (FB-.), a mycotoxin produced by the commonly occurring 
corn fungi, Fusarium moniliforme and Fusarium proliferacum, was 
hepatocarcinogenic in rats when fed in amounts of 69.3 pmol/kg diet (50 
ppm) for approximately 2 years (Gelderblom et al., 1991). Human esophageal 
cancer rate was high in areas where FBi concentration in corn reached 
approximately 11.1 pmol/kg (Sydenham et al., 1990). Corn products for human 
and animal consumption were determined to contain 0.3-4.2 umol FB;/kg 
(Hopmans and Murphy, 1993; Murphy et al., 1993; Sydenham et al., 1991). 
The hepatocarcinogenic effect of FBi can be evaluated in vivo by 
measuring changes in placental glutathione S-transferase (PGST) (Lebepe-
Mazur et al., 1994) and Y~glutamyl transferase (GGT) activity (Gelderblom 
et al., 1988), which are markers of altered hepatic foci (AHF) (Sato et 
al., 1984; Goldsworthy et al., 1985). Also, plasma alanine aminotransferase 
(.ALT) activity was related to fumonisin hepatotoxicity (Voss et al., 1992) 
and hepatocarcinogenesis in rats (Hendrich et al., 1993). Increased plasma 
total cholesterol was also an indicator of FBi toxicity in vervet monkeys 
(Fincham et al., 1992), and in rats (Hendrich et al., 1993). Production of 
prostaglandin E; (PGE;) and other eicosanoids from the cyclooxygenase 
pat.hway was stimulated in Yoshida hepatoma cells in rats and in human 
hepatocellular carcinomas (Trevisani et al., 1980; Hanai et al., 1993). 
Effects of FBi on PG production in rat liver have not been investigated 
yet. 
Fumonisin Bi can alter immunological functions mediating anti-tumor 
mechanisms. Macrophage structure and phagocytic function were down-
regulated in vitro by FB,. (Chatterjee and Mukherjee, 1994; Chatterjee et 
al., 1995) as was lymphocyte proliferation in response to 
lipopolysaccharides (LPS) (Dombrink-Kurtzman et al., 1994). The effects of 
in vivo administration of FB; produced both increases and decreases in 
plaque forming cell response in BALB/C mice depending upon the timing of 
t.he fumonisin injections and the number of injections (Martinova and 
Merrill, 1995). 
Efforts have been devoted to detoxifying FBi in several ways. 
Thermostability of FBi. proved to be great, because nearly 85% of FS-. was 
recovered after different heat treatments: 75°C for 135 min, 100°C for 45 
min, and 125°C for 5 min (Dupuy et al., 1993). Treatment of fumonisin-
contaminated corn with 2% ammonia for 4 days, a process that detoxified 
aflatoxin B;, led to slight reduction in the concentration of FB^ without 
decreasing the toxicity in rats (Norred et al., 1991). Hydrolyzed FBi, 
which was produced by boiling F. prolifaracum-conzaminated corn in 1.2% 
calcium hydroxide solution for 1 hr, was similar in toxicity to FBi when 
nutritional status of rats was adequate (Hendrich et al., 1993). In vitro 
toxicity studies on several analogs of FBi showed that the analogs 
containing FB;'s amine group and the tricarballylic side c.hains were .more 
toxic than FB., whereas the analog containing only the tricarballylic side 
chains was not to.xic (Kraus et al., 1992). The N-acetyl derivative of FB-. 
at 1 mM was less toxic in primary rat hepatocytes than FBi at the same 
concentration. In addition, rats fed N-acetyl-FB; at about 1.3 mmol/kg diet 
did not exhibit hepatic neoplastic nodules or increased hepatic GGT 
activity (Gelderblom et al., 1993). Therefore, FBi's amine group is likely 
to be critical for its toxicity. The N-acetyl-FB: may be produced during 
the isolation and purification of FBi from corn cultures of F. moniliforme. 
This paper describes a dedicated and more practical method to block FB;'s 
amine group by reacting the amine group with reducing sugars such as 
fructose in a Maillard reaction. It was hypothesized that modifying FB-. 
with fructose would reduce or prevent promotion of hepatocarcinogenesis and 
hepatotoxicity in rats. 
MATERIALS AND METHODS 
Preparation of Crude Pumonisin Bx 
Fumonisin B; is a class 28 carcinogen (International Agency for 
Research on Cancer, 1993) and standard safety precautions were taken during 
its handling. 
Fusariuw prolifaracum strain M5991 i'f rora Dr. Paul Nelson, 
Pennsylvania State University, College Station, PA) predominantly produces 
FB,. Sterile, aflatoxin-free corn was inoculated with lyophilized cultures 
of F. proliferatum strain M5991 which had been reconstituted in pH 7.4 
phosphate buffered saline. This corn culture was incubated at 22°C in the 
dark for 3 weeks. After incubation, freeze-dried corn culture was ground 
and extracted with 1:1 acetonitrile:water. The extract was partitioned with 
ethyl acetate, after which the water phase was loaded onto a 1 kg XAD-16 
column (7.5 x 100 cm, Sigma Chemical Co., St. Louis, MO). The column was 
washed with water, and FB; was eluted with 4 L methanol. The eluate was 
dried under vacuum, reconstituted in water and loaded onto a Lobar 
LiChroprep RP-8 column (25 x 310 mm; EM separations, Gibbstown, NJ). The 
column was washed with 20% acetonitrile : 80% water containing 0.1% 
trifluoroacetic acid (TFA) , and FB: was eluted with 50% acetonitrile : 50% 
water containing 0.1% TF.^i. The purity of the isolated FB-. was determined by 
analytical HPLC of the o-phthaldialdehyde (OPA)-derivative (Hopmans and 
-Murp.hy, 1993) . The FB-, standard curve was prepared with FB. generously 
donated by Dr. P. G. Thiel (Research Institute for Nutritional Diseases, 
South African Medical Research Council, South Africa) . The isolated FB-. was 
approximately 40% pure, containing 1.5 g FBt. The preparation also 
contained trace amounts of fumonisins B; and Bi. 
Preparation of Highly Purified Fumonisin Bi 
Liquid cultures were prepared as in Dantzer et al. (1996a) by 
inoculating capped baffled Erlenmeyer flasks containing 500 ml of modified 
Myro medium with a 4 day shake flask culture of F. proliferatum strain 
M5991. Fumo.nisin Bi was isolated and purified by the procedure as described 
in Dantzer et al. (1996b). Briefly, harvested liquid cultures were filtered 
and run over a series of chromatographic steps, including Amberlite XAD-16, 
reverse phase Lobar Co, ion exchange DEAE Sepharose, and reverse phase YMC 
C:j, until FB-^ purity >95% was obtained. Purified FBi. solutions were freeze-
dried and a dry weight was determined. The purified FB-. was dissolved 
volumecrically and assayed for FB. as described by Hopmans and Murphy 
(1993) . The mass of FBi, was calculated from the standard curve and compared 
with the weighed mass of freeze-dried FB,. This ratio was taken as the % 
purity of FBi (Dantzer et al., 1996b). The purity of the FB, was confirmed 
to be >95% by Dr. Ronald Plattner {USDA-ARS, National Center for 
Utilization Research, Peoria, IL). 
Preparation of Fumonisin Bi-Fructose Adduct 
Both crude and highly purified FB. were conjugated with fructose as 
described by Murphy et al. (1995). Briefly, 725 pM FB: in 50 mM potassium 
phosphate buffer, pH 7.0, containing 1 M fructose, was heated for 48 hours 
at 80°C. Less than 5% of the FB: was left unreacted with fructose. 
Fumonisin B:-fructose was hydrolyzed by refluxing in 2 N KOH for 2 h at 
100°C, after which the pH was adjusted to 2.8 with 2 N .HCl. All of the FB; 
could be recovered as hydrolyzed FB.. In addition, FBi was heated under the 
same conditions without fructose and retained 100% reactivity with OP.A. 
Diets 
Three experimental diets were fed to rats in each of the two studies. 
Basal diet supplying 40% of energy as fat was modified from AIN-7 6 
(.^ erican Institute of Nutrition, 1977) in the study feeding crude FB-., or 
from .a.IN-93G (American Institute of Nutrition, 1993) in the study feeding 
highly purified FB, (Table 1). Crude or highly purified FB,-containing 
diets were prepared by incorporating 69.3 pmol FB,/l<g diet into the basal 
diets. Crude or highly purified FBi reacted with fructose were incorporated 
into the basal diets at a level equivalent to 69.3 umol FB,/kg diet. Based 
on the proposed reaction between FB, and a reducing sugar such as fructose 
(Murphy et al., 1996), it was estimated that approximately 17 g unreacted 
fructose was added per kg of FB,-fructose diet. All the diets were stored 
at 4°C. 
Animals 
The use of animals and the experimental procedures were approved by 
the Iowa State University Animal Care Committee. In the experiment with 
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crude FB-., 20 10-day old male F344/N rats obtained from Harlan Sprague-
Dawley (Madison, WI) were injected intraperitoneally with 
diethylnitrosamine (DEN, 15 mg/kg body weight) in 0.1 ml corn oil. At 3 
weeks of age, the weaned rats were randomly assigned into one of the 3 
treatment groups with 6-7 rats each. In the experiment with highly purified 
F3:, 3 9 10-day old female F34 4/N rats obtained from Harlan Sprague-Dawley 
(Madison, Wisconsin) were initiated as described above, randomly assigned 
into the treatments with 12-15 rats each. In both experiments, rats were 
given free access to the experimental diets and water for 4 weeks in an 
animal facility with a 12-hr light/dark cycle maintained at 22-25°C and 50i 
humidity. Body weight and feed intake of the female rats were recorded 
weekly. 
Plasma and Liver Sample Prepaxa-tlons 
Part of the plasma obtained from heparinized blood was analyzed 
within 24 hours for ALT activity. The remaining plasma was stored at -80°C 
and later analyzed for plasma total cholesterol. 
The liver was perfused with 40 ml of Hank's balanced salt solution 
contai.ning 1% EDTA and 25 mM HEPES. The perfusate (10-12 ml) containing red 
blood ceils, Pitt cells, and other leukocytes was used as the source of 
effectors in the NK cell activity assay. 
Each of the 3 largest lobes of the liver was sliced into 1 cm slices. 
Three slices, one from each lobe, were immediately frozen as a block on dry 
ice and stored at -80°C. From each of the frozen liver blocks, two 10-um 
serial sections were cut with a Histostat Microtome (Model 855, Leica Inc., 
Deerfield, ID for later stainings for GGT activity and PGST. 
From each rat, 0.5 g minced liver portions were immediately 
homogenized in an ice bath with 10 passes of a Potter-Elvehjem homogenizer 
in 5 ml, pH 7.4, 50 mM potassium phosphate buffer containing 4.2 mM acetyl 
salicylic acid. The liver homogenates were frozen on dry ice and stored at 
-80°C for later analyses of endogenous hepatic PGF:^ and PGE; levels. 
Plasma Totial Cholesterol Concentration and Alanine Aminotransferase 
Activity 
Plasma total cholesterol concentration was determined by using Sigma 
diagnostic kit, procedure 352-3 (Sigma Chemical Co., St. Louis, MO). Plasma 
PlLT activity was measured by using Sigma diagnostic kit for 
glutamate/pyruvate transaminase optimized ALT assay (Sigma Chemical Co., 
St. Louis, MO). 
Histochemical Staining and Computerized Stereology of AHF 
One of the frozen serial sections was stained for the presence of 
PGST-positive altered hepatic foci (AHF). Placental glutathione S-
transferase was detected by the peroxidase-anti-peroxidase (P.'^P) method 
using a Vectastain ABC avidin-biotin universal rabbit P.OiP kit (Vector 
Laboratories, 3urlingame, CA). Placental glutathione S-transferase was 
purified by the method of Sato et al. (1984) and rabbit anti-rat PGST 
antiserum was prepared as described by Hendrich and Pitot (1987). 
The second frozen serial section was stained for GGT activity as 
described by Rutenburg et al. (1968). The substrate for GGT was gamma-
glutamyl-4-naphthylamide (GMNA) (United States Biochemical Corp., 
Cleveland, OH). 
.Altered hepatic foci were quantified via computerized stereology by 
slight modification of a program which was developed by Dr. Harold Campbell 
at McArdle Laboratories, University of Wisconsin, Madiso.n (Campbell et al., 
1986). Two magnified images of the serial sections stained for GGT activity 
and PGST were projected onto a Summagraphics Microgrid II digitizer screen 
and automatically plotted on an HP 9872C plotter controlled by an HP9845B 
computer (Hewlett-Packard, Palo Alto, CA) connected to an LA120 printer 
(Digital Equipment Corp., Maynard, MA) to quantify AHF. 
Radioimmtinoassay for Endogenous Liver Prostaglandin Fja and E2 Levels 
Endogenous liver PGF:a and PGE2 levels were determined by 
radioimmunoassay according to the method of McCosh et al. (1976). Anti-rat 
?GF:a rabbit antiserum was purchased from Sigma Chemical Co., St. Louis, 
MO. Anti-rat PGE; rabbit antiserum was a gift from Dr. Jaqueline Dupont, 
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USDA/ARS, Belcsville, MD. Goat anti-rabbit gamma globulin (ARGG) was 
obtained from Western Chemical Research Corp., Fort Collins, CO. 
Concentrated -H-PGF;a and 'H-PGE; with specific activities of 168.0 Ci/mmol 
and 154.0 Ci/mmol, respectively, were purchased from Dupont New England 
Nuclear, Boston, MA. Standards of PGF;^ and PGE; were obtained from Sigma 
Chemical Co., St. Louis, MO. Scintiverse BD (Fisher Chemical, Fair Lawn, 
NJ) was added to each tube before counting. Sample-containing tubes were 
run in duplicate. Total count tubes and background tubes were counted in 
triplicate. Six replicates were made to determine total binding. Along v;ith 
the samples, a standard curve was run in duplicate, one set at the 
beginning of the sample run and the other set at the end. Radioactivity was 
determined as cpm using a Packard liquid scintillation analyzer model 1900 
TR (Packard Instrument Co., Downers Grove, IL). 
Natural Tumor Cytotoxicity Assay 
In the e.xperiment with purified FB-., tumor cytoto.xicity of liver NK 
cells was assessed on the first 7 animals sacrificed from each group due to 
time constrai.'its in performing the assay. The liver perfusate containing 
Pitt cells was layered over 3 ml of Accupaque (Accurate Chemical Co., 
Westbury, NY). The cells were centrifuged for 15 min at 15,000 rpm in a 
swinging bucket centrifuge (Model CR312, Jouan, Winchester, VA). The cells 
at the interface of the density gradient media were collected, washed twice 
with complete media (RPMI-1540 supplemented with 50 pg/ml gentamicin, 25 mM 
HEPES, 2 .naM L-glutamine (all from Life Technologies, Gaithersburg, MD) , and 
10% fetal bovine serum (FBS) (JRH Scientific, Lenexa, KS), and enumerated 
on a Celltrack II (NOVA Biomedical, Waltham, MA). The cells from each 
sample were diluted to 5 x 10® and plated in 96 well plates (Model 3595, 
Costar, Cambridge, MA) to obtain 20, 10, 5, and 2.5 x 10^ cells 
(effectors)/well in triplicate. The targets for the assay were YAC-1 cells, 
which had been labeled with 200 pCi of ^"Cr (401 mCi/mg, Dupont New England 
Nuclear, Boston, MA) for 70 min, and maintained in complete media. The 
targets were washed 3 times prior to dilution and 10'' targets were plated 
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in each well of the NK assay including control wells to determine 
spontaneous and maximum release. The plates were incubated for 4.5 hours in 
a humidified CO; incubator (5% CO;, 95% air) (Fisher Scientific, Chicago, 
ID . -J^t the end of the incubation the plate was centrifuged at 500 rpm for 
5 min, and 100 ul of supernatant was collected to determine the amount of 
'"Cr released by dying cells using a Gamma Trac 1191 (TM Analytic, Inc., 
Elk Grove Village, IL). The cpm detected were used to calculate the lytic 
units (LU) of activity at 20% lysis in lO' effectors using a computer 
program. 
Sta'tis'tical Analysis 
The liver PGF;a and PGE; concentrations were determined by a computer 
program based on a logit transformation of the standard curve (Duddleson et 
al., 1972). One-way ANOVA was performed to analyze feed consumption, body 
weight, plasma total cholesterol level and AiT activity, endogenous hepatic 
?GF;j and ?GE; concentrations, and natural tumor cytotoxicity, using the 
Statistical .Analysis System (Gary, NC). Student's t-test was performed to 
compare group differences after ANOVA. A P value of <0.05 was considered to 
be statistically significant. For the analysis of computerized stereology 
of AHF, only the means and standard deviations were given because the means 
equalled zero in basal and FBi-fructose groups. 
RESULTS 
Experiment. 1. Male Rats Fed Crude Fumonisin Bi 
In comparison with the rats fed basal diet and the rats fed FB--
fructose, the FB,-fed rats had significantly increased plasma total 
cholesterol concentration and ALT activity by 85% (P<0.01} and 100% 
(P<0.05), respectively (Table 3). 
The PGF;a concentration was significantly increased by appro.ximately 
51% in the rats fed FB: as compared with those in the other groups (P<0.05) 
(Table 3) . There were no significant differences in PGE; levels among the 
groups (Table 3) . 
-All FB'.-fed rats had both PGST- and GGT-positive AHF. The average 
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PGST-positive AHF area percentage was 5.0 ± 6.3, and the average GGT-
positive AJiF area percentage was 1 ± 1 in the rats fed FBi at 69.3 ymol/kg 
diet (Table 4). There were no detectable PGST- or GGT-positive .AHF in the 
group fed 69.3 umol/kg FB-. reacted with fructose or in the control group 
(Table 4). 
EXPERIMENT 2. Female Ratis Fed Highly Pvirified Fumonisln Bx 
The average daily feed intake in F3i group, FB--fructose group and 
basal group was 11 ± 1 g, 13 ± 2 g and 13 ± 1 g, respectively. There were 
.-:o significant differences in the total feed intake or the average daily-
feed intake among the three groups (Table 2). 
The rats in the FBi.-treated group had significant reductions in both 
body weight (by 12%, P<0.05) and body weight gain (by 16%, P<0.05) as 
compared with the rats in the groups fed F3:-fructose and basal diet (Table 
2 )  .  
In comparison with the basal group and the group fed FB-.-fructose, 
rats fed FB. at 69.3 umol/kg diet had significantly increased plasma total 
cholesterol concentration and .ALT activity by about 2.3 fold (P<0.01) and 
1.7 fold (P<0.05), respectively (Table 3). 
The PGFca and PGE; concentrations were both significantly increased by 
twofold in rats fed 69.3 pmol/kg FBi-containing diet as compared with those 
in the other groups (P<0.05) (Table 3). 
.^ 11 of the rats fed FB,. developed PGST- and GGT-positive AHF. The 
average number of PGST-positive AHF and the average PGST-positive AHF area 
percentage were 50 ± 17 and 68 ± 18, respectively, and the average number 
of GGT-positive AHF and the average GGT-positive AHF area percentage were 
45 ± 13 and 61 ± 13, respectively, in the rats fed FBi (Table 4). There 
were no detectable PGST- or GGT-positive A.HF in either the group fed FBi-
fructose or basal diet (Table 4). 
Compared with the control rats, tumor cytotoxicity was significantly 
suppressed in animals fed FB,. (P<0.03), and significantly elevated in 
animals fed FB,-fructose diet (P<0.01) (Fig. 1). Thus, feeding highly 
purified FB-. or FB-.-fructose induced significant and opposing changes in 
liver tiumor cytotoxicity. 
DISCUSSION 
These studies demonstrated that subjecting FB, to nonenzymatic 
browning conditions with fructose eliminated FB, toxicity as reflected in 
body weight, plasma total cholesterol concentration and ALT activity, 
development of GGT- and PGST-positive AHF, and concentrations of endogenous 
hepatic PGF:c and PGE;. Loss of amine group reactivity towards OPA was taken 
as an indication that the amine had condensed with fructose (Murphy et al., 
1995). Results with either crude or highly purified FBi were generally 
similar, showing detoxification of FB-, because in both cases FB; reacted 
with fructose did not promote hepatocarcinogenesis in rats, did not 
increase plasma cholesterol concentration, plasma ALT activity or hepatic 
PGFzj, whereas feeding crude or highly purified FBi significantly increased 
ail of these parameters compared with rats fed a basal diet (Tables 3) . The 
greater development of PGST- and GGT-positive AHF, by 5-fold and 13-foid, 
respectively, caused by highly purified FBi compared with crude FB, (Table 
4), maybe due simply to inherent variability of the two cohorts of rats in 
their responsiveness to the carcinogenesis protocol used. Rats are highly 
variable in individual response to such protocols. Other signs of FB-. 
to.xicity were quite similar whether crude or purified FB. was fed. This 
result may suggest that females are more susceptible to promotion of cancer 
by FB-. than the males, but no other studies have examined this. 
The chemical modification of FBi by fructose by a Maillard reaction 
probably caused the formation of a Schiff's base, FBi-fructose adduct, in 
which the FB; amine group was combined with the fructose ketone. The 
addition of the bulky fructose did not cause FBi to be less absorbed in the 
intestine even though this may increase both water-solubility and molecular 
size (Hopmans et al., submitted). At the molecular level, FBi toxicity is 
most likely due to its inhibition of ceramide synthase, a key enzyme in de 
novo sphingolipid biosynthesis (Wang et al., 1991). Perhaps the presence of 
fructose blocked the inhibitory binding of FB; to ceramide synthase. 
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The putative effectiveness of the detoxification of FB; by reaction 
with fructose suggested that the amine group of FBi was critical to FB-. 
toxicity. This was in accordance with another study in which the N-acetyl 
derivative of FBi showed no hepatotoxicity and no hepatocarcinogenicity 
(Gelderblom et al., 1993). 
The significant reductions in body weight and body weight gain of 
female rats fed FBi compared with che other groups were accompanied by 
normal feed consumption (Table 2). This did not agree with another study in 
which both body weight and feed intake in male Sprague-Dawley rats were 
significantly decreased after intraperitoneal injection of FB-. (Bondy et 
al., 1995). Neither body weight nor feed intalce was signif icantly decreased 
after FB-. consumption by male and female Fischer 34 4 rats (Voss et al., 
1995). The difference between our results and the others cannot be readily 
explained. 
Fumonisin E-.-induced hypercholesterole.mia as observed in the present 
studies {Table 3) was reported in vervet monkeys (Fincham et al., 1992), as 
well as in rats fed FBt (Hendrich et al., 1993). Hypercholesterolemia is an 
observed effect of other tumor-promoting agents and to.xicants, such as 
phenobarbital (Katayama et al., 1991). The hypercholesterolemic mechanism, 
of FBi is unknown. 
In agreement with the findings of Hendrich et al.(1993), FB-. fed to 
rats at 69.3 pmol/kg diet for 4 weeks increased not only plasma total 
cholesterol, but plasma ALT activity as well (Table 3). Elevated plasma ALT 
activity indicated hepatocyte membrane damage which led to the leakage of 
•ALT into the blood. Such damage was associated with the development of .AHF 
caused by FBi (Hendrich et al., 1993). 
Placental glutathione S-transferase-positive AHF and GGT-positive .AHF 
were found only in FBi-fed rats in both studies (Table 4). Placental 
glutathione S-transferase and GGT are useful markers of FB; 
hepatocarcinogenesis. The induction of PGST could be demonstrated in single 
putatively initiated hepatocytes within 48 hours after DEN treatment (Mcore 
et al., 1987). Both PGST and GGT persisted during hepatocarcinogenesis 
(Kendrich and Pitoc, 1987). In the present study. Placental glutathione S-
transferase- and GGT-posicive AHF were detected after 4 weeks of FB-, 
treatment. This indicated that both PGST and GGT were induced at an early 
stage of hepatocarcinogenesis and could serve as sensitive markers of FB-.-
induced hepatocarcinogenesis. Because PGST- and GGT-positive AKF were 
virtually undetectable in DEN-initiated rats fed FB.. reacted with fructose, 
FBi promotion of carcinogenesis may be blocked by modifying FBi. with 
fructose. 
Only FBi-treated rats showed significantly greater amounts of 
endogenous PGF:a and PGE: compared with the control group, and PGST- and 
GGT-positive AHF were only present in FBi-fed rats. The elevation of 
hepatic PGFi^ and PGE; concentrations paralleled the induction of AHF in the 
liver. Therefore, increased PG production is related to promotion of rat 
.hepatocarcinogenesis caused by FBi.. Both PGF:c> and PGE; may contribute to 
cell proliferation in the liver during FBi treatment. Prostaglandins of the 
F series stimulated the proliferation of neonatal rat hepatocytes (Armato 
and Ajidreis, 1983) . Prostaglandins including PGF;-, and PGE; also played a 
role in proliferation of .hepatoma cells (Trevisani et al., 1980). Direct 
evidence of stimulatory effect of PGs on the proliferation of hepatoma 
cells was shown by the reversal of decreased hepatoma cell numbers by PGE; 
in indomethacin-treated rats (Trevisani et al., 1980). 
Prostaglandins may also exert indirect effects on proliferation of 
tumor cells by suppressing the local immune response. Prostaglandins were 
able to make macrophages and/or lymphocytes less sensitive to various 
stimuli (Pelus and Strausser, 1977; Schultz et al., 1978). Moreover, 
prostaglandin E; suppressed NK cells and lymphokine-activated killer (LAK) 
cells (Ohnishi et al., 1991; Roth and Golub, 1993; Baxevanis et al., 1993). 
The present studies showed that hepatic PGF;^ and PGE; concentrations were 
significantly increased in FBi-induced promotion of rat 
hepatocarcinogenesis (Tables 3,4), and in the female rats fed purified FB. 
liver-associated anti-tumor response was decreased (Figure 1). However, the 
mechanism for en.hancement of tumor cytotoxicity in the FB-.-fructose fed 
38 
group is not clear as this group did not differ from the basal diet group 
in any of the other measures. The tumor cytotoxic cells of the liver are 
Pitt cells, which are similar to blood NK cells, but with higher lytic 
activity. The possible immune-enhancing effect of FBi-fructose deserves 
further study. 
The mechanism of FB,-induced carcinogenesis is still not fully 
understood. Fumonisin B-, is an inhibitor of sphingolipid synthesis (Wang et 
al., 1991). Sphingolipids may be anticarcinogenic because they were down-
regulators of protein kinase C (Merrill, 1991), which could affect many 
enzyme activities after it was activated by carcinogens (Weinstein, 1987). 
It is not known whether FBi can stimulate phospholipase which hydrolyzes 
phospholipids to release the PG precursor, arachidonate, or activate 
cyclooxygenase to produce more PGs in the liver. Prostaglandin F:a was 
shown to sti.tiuiate the formation of intracellular diacylglycerol in Swiss 
3T3 cells (Macphee, et al., 1984), which can in turn activate protein 
kinase C. Perhaps FB>.-induced alteration of sphingolipid metabolism 
stimulates PG production, by an unknown mechanism. 
Possibly decreased inhibitory binding of FB: to ceramide synthase as 
a result of FBi reaction with fructose may be the mechanism of FB-. 
deto.xification in this experiment. Further study is needed to identify the 
structure of the putative FBi-fructose conjugate and investigate its 
stability, possible processing occurrence, bioavailability and toxicity. 
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Table 1. Basal Diet: Composit:ion^ 
Crude FBi Expt. Purified FB: Expt. 
Ingredient 
Beef Tallow 
Corn oil 
Soybean oil 
Casein 
Corn starch 
Dextrose 
Cellulose 
Vitamin Mix (AIN-7 6) 
Vitamin Mix (AIN-93G-VX) 
Mineral Mix (AIN-7 6) 
Mineral Mix (AIN-93G-MX) 
CaCO] 
Choline Chloride 
L-Methicnine 
Ascorbate 
L-Cyscine 
Choline Bitartrate 
TBHQ 
(g/kg) 
139.6 
66.5 
224 .1 
228.5 
224 .1 
56.0 
11.2 
39.2 
5.0 
2 . 2  
3.4 
O.I 
(g/kg) 
139.6 
66.5 
224.1 
228 . 5 
224.1 
56.0 
1 0 . 0  
39.2 
3.0 
2.5 
0 . 014 
"Basal diet modified from .AIN-76 was used in crude FBi experiment; Basal 
diet modified from AIN-93G was used in highly purified FBi experiment. 
Table 2. Differences in Body Weight but not Feed Intake among Female Rats 
Fed Fumonisin Bi (FBt) , FBi Reacted with Fructose (FBi-fru.) or an Basal 
Diet 
Group 
Basal FBi.-fru. FBi 
Total feed 
intake (g) 366 ± 37 354 ± 43 320 ± 25 
Average daily-
feed intake (g/d) 13 ± 1 13 ± 2 11 ± 1 
Final 
body weight (g) 191 ± 19 191 ± 10 171 t 14' 
Body weight 
increase (g) 128 ± 15 128 ± 8 108 ± 15' 
'Significantly different from the basal group, P<0.05. 
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Table 3. Increased Plasma Total Cholesterol Concentration, Plasma 
Alanine Aminotrsurisferase (ALT) Activity, and Endogenous Hepatic 
Prostaglandin (PG) Production in Rats Fed Crude or Highly Purified 
Pumonisin Bi (FBi) , Compared with Feeding FBi Reacted with Fructose (FBi-
fru.) or a Basal Diet 
Plasma 
Cholesterol 
(tng/dl) 
Plasma Heoatic Heoatic 
ALT activity PGF;ci PGE; 
(u/1! (ng/g) (ng/g) 
ExDt. 1. Male rats fed crude FB: 
Basal 143 ± 24 
(n=61 
FB- 261 ± 45" 
(n=7) 
FB-.-fru. 145 ± 33 
) 
58 ± 13 
105 ± 58" 
51 ± 3 
49 ± 8 4 ± 1 
77 ± 22" ± 2 
53 ± 13 5 £ 3 
£xpt. 2. Female rats fed highly purified FB. 
Basal 113 ± 28 45 ± 11 5 ± 2 2 ± 1 
(n=15) 
FB; 261 ± 68" 75 ± 22* 10 + 4" 4 ± 2" 
9n=i2) 
F3;-fru. 121+27 50 ± 11 5 ± 3 2 ± 1 
(n=12) 
'Significantly different from the basal group in respective study, ?<0.05. 
"Significantly different from the basal group in respective study, P<0.01. 
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Table 4. Placental Glutathione S-Transferase (PGST)- and Y'Glutamyl 
Tramsferase (GGT)-Positive Altered Hepatic Foci (AHF) Occurred Only in 
Fed either Crude Fumonisin Bi (FBi) or Highly Purified FBi 
# of PGST # of GGT % of PGST % of GGT 
lesions lesions Lesion area lesion area 
Sxpc. 1. Male rats fed crude FB; 
Basal {n=6) 0 0 
FB: (n=7) 5 ± 6 i ± 1 
:B;-fru. (n=7) 0 0 
Sxpt. 2. Female rats fed highly purified FB-
Basal 0 0 0 0 
:n=15) 
Pure FB: =0 ±17 45 ± 13 68 ±18 61 r 13 
;n=12) 
FB-.-fru. 0 0 0 0 
;n=12) 
(0 
u 
U 
O 
CO 
t-
25 
20 
15 
c: 10 
3 
O 
Basal FB, FBi-fructose 
Figure 1. Tumor cytotoxicity of liver-associated NK cells against YAC-1 
target cells, expressed as mean lytic units (LU) ± SE (n = 7/group), in 
female rats fed ftimonisin Bi (FBi) , FBi reacted with fructose (FBi-fructose) 
or a basal diet. Treatments marked by different letters were significantly 
different from basal group: b: P<0.03; c: P<0.01. 
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SUPPRESSION OF FXJMONISIN Bi-PRCMOTED SAT HEPATOCARCINOGENESIS BY GENISTEIN 
AND DAIDZEIN DEPENDS UPON FUMONISIN Bi DOSE 
A paper to be submitted to The Journal of Nutrition 
Zhibin Lu, Tong T. Song, William R. Dantzer, Patricia A. Murphy & Suzanne 
Hendrich 
ABSTRACT 
To cest our hypothesis that isoflavones may suppress tumor promotion 
by fumonisin Bt, female F344/N rats initiated with diethylnitrosamine were 
fed 1 mmol isoflavones with 18, 35 and 70 uniol FBt per kg diet for 4 weeks. 
Plasma total cholesterol (TC) concentration, alanine aminotransferase [ALT) 
activity, and hepatic prostaglandin production were significantly greater 
in che rats fed FB-. i70 pmol/kg diet)-containing diets with and without 
isoflavones than in control rats. Placental glutathione S-transferase 
(PGST)-positive and gamma-glutamyltransferase (GGT)-positive altered 
hepatic foci (AHF) developed in the rats fed diets containing 70 pmol 
FB-./kg regardless of isoflavone content. Increased plasma TC (91% over that 
of the control) was found in the animals fed 35 umol FBi/kg diet, and the 
increase in plasma TC was diminished by isoflavones. Plasma ALT activity of 
the rats fed 35 umol FB-,/kg diet was significantly raised by 86%. 
Isoflavones normalized plasma ALT activity to the control level when co­
administered with 35 pmol FB-./kg diet. Fumonisin B^ at 13 and 35 pmol/kg 
diet did not significantly affect hepatic prostaglandin concentrations 
compared with the control diet, neither did isoflavones at 1 mmol/kg diet. 
Rats fed the diet containing 35 nmol/kg FB. developed both PGST- and GGT-
positive A.HF, but adding isoflavones to this FB-.-containing diet 
significantly suppressed the development of PGST- and GGT-positive .AHF by 
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75% and 80%, respectively. These results showed that isoflavones at 1 
mmol/kg diet suppressed FBi tumor promotion only at an FB-. dose of 35 
umol/kg diet and not when 70 pmol FB\/kg was fed. 
INTRODUCTION 
Greater soybean consumption was associated with lower risk of breast 
cancer in .a.sian countries (reviewed by Adlercreutz et al., 1995). Animal 
studies showed that soybeans played a protective role against 
carcinogenesis (Barnes et al., 1990; Hawrylewicz et al., 1991; Troll et 
al., 1980). Isoflavones, mainly genistein, daidzein and their glucoside 
conjugates, are abundant in soybean foods (0.2-1.5 mg/g) (Wang and Murphy, 
1994). Soybean isoflavones may contribute in large part to the 
anticarcinogenic effects associated with soybean consumption (Lamartiniere 
et al., 1995; Lee et al., 1995). 
Fumonisin B-. (F3;) is a myccto.xin produced primarily by the commonly 
occurring corn fungi Fusariu-Ti moniliforme and Fusarium prclifaratum. 
Fumonisin B; has recently been listed as a class 2B carcinogen 
(International Agency for Research on Cancer, 1993). In addition, fumonisin 
B; is a potent rat hepatocarcinogen (Gelderblom et al., 1991). Our previous 
studies showed that FBi at 70 pmol/kg diet rapidly promoted 
diethylnitrosamine (DEN)-initiated rats in 4 weeks (Hendrich et al., 1993; 
Lu et al., 1997a) . The natural occurrence of FBi in corn-based human foods 
and animal feeds commonly ranged from 0.3-4.2 umol/kg (Hopmans and Murphy, 
1993; Murphy et al., 1993; Sydenham et al., 1991) . 
Several biomarkers have been used to study FBi hepatocarcinogenicity. 
Placental glutathione S-transferase (PGST) and gamma-glutamyltransferase 
(GGT) were markers of altered hepatic foci (A.HF) (Goldsworthy and Pitot, 
1985; Sato et al., 1984), and effectively scored certain types of chemical 
hepatocarcinogenesis (Hendrich et al., 1987). The development of GGT- or 
PGST-positive AHF, or both, was also demonstrated in F3-.-promoted 
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hepatocarcinogenesis in rats (Gelderblom et al., 1988; Lebepe-Mazur et al., 
1995; Lu et al., 1997a). Because of the early occurrence of PGST induction, 
which was evident within 48 h in single hepatocytes after DEN initiation 
(Moore et al., 1987), and because of the persistence of both PGST and GGT 
during hepatocarcinogenesis (.Hendrich et al., 1987), these two enzymes can 
serve as sensitive biomarkers of early stages of carcinogenesis in the 
liver. Increased plasma or serum total cholesterol CTC) level and alani.'^.e 
aminotransferase (ALT) activity have been associated with FBi-promoted 
hepatocarcinogenesis. Fusarium proliferacum-fermented corn providing FB; 
(70 umol/kg diet) to DEN-i.nitiated rats significantly increased plasma TC 
level and ALT activity while causing hepatocellular adenomas (Hendrich et 
al., 1993). In addition, greater hepatic prostaglandin production was 
related to FB. tumor promotion in rat liver (Lu et al., 1997a). These 
biomarkers of FB; tumor promotion can be readily used to study the 
anticarcinogenic effects of isoflavones. 
Most animal studies on the anticarcinogenic ability of isoflavones 
utilized rodent mammary carcinogenesis models. Because FB: is almost always 
found in appreciable amounts in corn-based human foods and animal feeds, 
and it is potentially a human carcinogen, investigating whether isoflavones 
exerc anticancer effects on FBi-promoted carcinogenesis is warranted. Using 
a 2-stage hepatocarcinogenesis model, i.e. DEN (15 mg/kg body weight) 
initiation of rats followed by FBi (70 lomol/kg diet) promotion for 4 weeks, 
our previous study demonstrated that feeding isoflavone extract providing 1 
.mmol isoflavones/kg diet suppressed FBi. tumor promotion, as reflected in 
reduced hepatic prostaglandin F;, production and plasma ALT activity, and 
suppressed development of PGST-positive AHF (Hendrich et al., 1997). 
The present studies were designed to determine whether our previous 
finding can be extended from soy isoflavone extract to isoflavones with the 
same carcinogenesis model. On selection of FB-. concentrations, 35 and 18 
umol in addition to 70 umol FB-./kg diet were chosen to approach more 
closely the natural occurrence of FB; in corn-based human, foods and animal 
feeds. Because isoflavone extract was able to suppress FB:-promoted 
hepatocarcinogenesis, and isoflavones were considered to be responsible in 
large part for the effect, it was hypothesized that dietary isoflavones may 
at least partly inhibit rat hepatocarcinogenesis promoted by FBi. 
MATERIALS AND METHODS 
Syntheses of Daidzein and Genistein 
Daidzein was synthesized in high yield (82%) via cyclization of 
2, 4, 4'-trihydroxydeoxy benzoin (THE) which was produced as reported (Chang 
et al., 1994). Two hundred mg of THE were dissolved in 8 .mL N, N-dimethyl 
formamide in a 500 mL beaker. Following addition of 4 mL boron trifluoride-
diethyl ether, the reaction mixture was heated in a Keamore 088-332 
microwave oven for 21 s at medium (40%) power output. Then 4 mL 
methanesulfonyl chloride was added and the mi.xture was heated in the 
microwave oven for 70 s at the same power level. A light-yellow precipitate 
appeared after 400 mL cold water was added to the hot reaction mi.xture. The 
precipitate was collected by centrifugation at 170,000 rpm (Beckman j2-21) 
for 10 min., washed with water, dissolved in methanol, and recrysallized by 
adding water. The purity (>98%) of daidzein was determined by retention 
time on HPLC, spectral analysis and melting point. The HPLC system 
consisted of a YMC-pack ODS-AM-303 column (5 ^im, 25 cm x 4.6 cm), a Beckman 
Model 126 pump, a Beclonan Model 168 photodiode array detector monitoring 
200-300 nm, an IBM computer with Beckman Gold system HPLC data processing 
software, and a Beckman Model 507 autosampler. The spectral analysis of 
daidzein was performed with a Beckman DU 7400 spectrophotometer, and the 
melting point of daidzein was measured on a Perkin Elmer 7 series/Unix 
differential scanning calorimeter. 
Genistein was synthesized as reported (Chang et al., 1994). The 
purity (>98%) was determ.ined by the same methods used for daidzein. 
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Prepara-tion of Purified Fumonisin 
Fumonisin Bi is a class 2B carcinogen (International Agency for 
Research on Cancer, 1993), and standard safety precautions were taken 
during its handling. 
Liquid cultures of F. Prolifaratum strain M5991 were prepared as in 
Dantzer et al. (1996a). Fusarium Proliferatum strain M5991, a predominant 
producer of FB-, was a gift from Dr. Paul Nelson (Pennsylvania State 
University, State College, PA) . Fumonisin B^ was purified by the same 
procedure as described by Dantzer et al. (1996b). Purified FB; solutions 
were freeze-dried, and a dry weight was determined. The purified FB-. was 
dissolved volumetrically and assayed for FBi as described by .Hopmans and 
Murphy (1993). The mass of FB, was calculated from the standard curve and 
compared with the weighed mass of freeze-dried FB:. This ratio was taken as 
the percent purity of FB, (Dantzer et al., 1996b). The purity of the FB-_ 
was confirmed to be >95% by Dr. Ronald Plattner (USDA-ARS, National Center 
for Utilization Research, Peoria, ID and Dr. Chet Mirocha (University of 
Minnesota, St. Paul, MN). 
Diets 
All dietary ingredients except isoflavones and FB; were obtained from 
Harlan Teklad (Madison, WI) . In both e.xperiments, a basal diet without 
incorporation of isoflavones and FB, was used as a control. The basal diet 
supplying 40% of energy as fat was modified from AIN-93G (American 
Institute of Nutrition, 1993). The ingredients of the basal diet were beef 
tallow 140 g/kg; soybean oil 67 g/kg; casein 224 g/kg; corn starch 223 
g/kg; dextrose 224 g/kg; cellulose 56 g/kg; vitamin mix (AIN-93G-VX), 10 
g/kg; mineral mix (AIN-93G-MX), 39 g/kg; L-cystine, 3 g/kg; choline 
bitartrate, 2.5 g/kg; and TBHQ, 0.014 g/kg. In Experiment 1, eight 
e.xperimental diets including the basal diet were fed to DEN-initiated rats 
for 4 weeks (Table 1). Diets containing genistein (1 mmol/kg diet), 
daidzein (I mmol/kg diet) or their equimolar combination (1 mmol total 
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isoflavones/icg diet) were prepared by incorporating isoflavones into the 
basal diet. Fumonisin Bi (69.3 pmol/kg diet) was incorporated into the 
basal diet alone, with each isoflavone, or with isoflavone combination. In 
Experiment 2, six experimental diets including the basal diet were fed to 
•EN-initiated-rats for 4 weeks (Table 1). Equimolar combination of 
genistein and daidzein (1 mmol total isoflavones/kg diet), which 
appro.ximated soy isoflavone composition, was incorporated into the basal 
diet alone, with 18 umol FBi/kg diet, or with 35 umol FB;/kg diet. In 
addition, fumonisin B-. alone was incorporated into the basal diet at IS and 
35 umol/!cg diet. .^11 the experimental diets were stored at 4°C before use. 
Animals 
The use of animals and the e.xperimental procedure were approved by 
the Iowa State University Animal Care Center Committee. In both 
experiments, ten-day-old female F344/N rats obtained from Harlan Sprague-
Dawley (Madison, WI) were injected intraperitoneally with DEN (15 mg/kg 
body weight) in 0.1 mL corn oil. At 3 weeks of age, the weaned rats were 
randomly assigned into one of the 8 (E.xperiment 1) or 6 (Experiment 2) 
treatment groups with 12 rats each. The rats were given free access to the 
experimental diets and water for 4 weeks in an animal facility with a i2-h 
light/dark cycle maintained at 22-25°C and 50% humidity. Body weight and 
feed intake of the rats v/ere recorded weekly. 
Plasma cind Liver Sample Preparation 
Part of the plasma obtained from heparinized blood was analyzed 
within 24 h for ALT activity. The remai.ning plasma was stored at -80°C and 
later analyzed for plasma TC concentration. 
The liver was excised and each of the three largest lobes of the 
liver was sliced into 1 cm slices. Three slices, one from each lobe, were 
immediately frozen as a block on dry ice and stored at -80°C. From each of 
the frozen liver blocks, two 10-um serial sections were cut with a 
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Hiscosrat: Microtome (Model 855, Leica Inc., Deerfield, ID for later 
staining for GGT and PGST. 
From each rat, 0.5 g of minced liver portions was immediately 
homogenized in an ice bath with 10 passes of a Potter-Elvehjem homogenizer 
in 5 ml, pH 7.4, 50 mM potassium phosphate buffer containing 4.2 mM 
acetylsalicylic acid. The liver homogenates were frozen on dry ice and 
stored at -80°C for later analyses of endogenous hepatic PGF;^ and PGE: 
levels. 
Plasma Total Cholesterol Concentration and Alanine Aminotransferase 
Activity 
Plasma TC concentration was determined by using Sigma diagnostic kit, 
procedure 352-3 {Sigma Chemical Co., St. Louis, MO). Plasma activity 
was .measured by using Sigma diagnostic kit for glutamate/pyruvate 
transaminase optimized .A.LT assay (Sigma Chemical Co., St. Louis, MO). 
Staining and Quantification of Altered Hepatic Foci 
One of the frozen serial sections was stained for the presence of 
PGST-positive AHF. Placental glutat.hione S-transferase was detected by 
using a Vectastain ABC Elite anti-rabbit IgG kit (Vector Laboratories, 
Burlingame, CA). Placental glutathione S-transferase was purified by the 
method of Sato et al. (1984), and rabbit anti-rat PGST antiserum was 
prepared as described by Hendrich and Pitot (1987). 
The second frozen serial section was stained for GGT activity as 
described by Rutenburg et al. (1968). The substrate for GGT was gamma-
glutamyl-4-naphthylamide (GMN.A) (United States Biochemical Corp., 
Cleveland, OH). 
Altered hepatic foci were quantified via computerized stereology or 
computer-assisted image analysis. The computerized stereology used a 
slightly modified program developed by Dr. Harold Campbell at McArdle 
Laboratories, University of Wisconsin, Madison (Campbell et al., 1986). Two 
magnified images of the serial sections stained for GGT and PGST were 
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projected onto a Summagraphics Microgrid II digitizer screen and 
automatically plotted on an HP 9S72C plotter controlled by an HP9845B 
computer (Hewlett-packard, Palo Alto, CA) connected to an LA 120 printer 
(Digital Equipment Corp., Maryland, MA) to quantify AHF. In computer-
assisted image analysis, images of the serial sections stained for PGST and 
GGT wer"? taken by a Sony 3-chip color video camera DXC-3000A, digitally 
transferred from the camera to a SiliconGraphics Indigo 2 XZ computer work 
station (SiliconGraphics, Mountain View, CA), and analyzed with Visilog 
image analysis software (Version 5.0.2, Noesis, St. Laurent, Quebec, 
Canada). The images were broken down to red, blue and green colors, 
followed by contrast enhancement. The whole tissue was outlined to obtain 
its total area after erosion was processed to delete any edge effect 
(artifactual darkening around the tissue edge as a result of staining 
procedure) . .A threshold of pi.xel values was selected for the lesions, so 
that only lesions were counted for calculation of lesion area. Calibration 
for the image analysis was accurate to mm. 
Radioimmunoassay for Hepatic Prostaglandin Fjo: and Ej Levels 
Endogenous liver PGF;i and prostaglandin E; (PGE;) levels were 
determined by radioimmunoassay according to the method of McCosh et al. 
(1976). Anti-rat PGF;^ rabbit antiserum was purchased from Sigma Chemical 
Co., St. Louis, MO. Anti-rat PGE; rabbit antiserum was a gift from Dr. 
Jaqueline Dupont, USDA-.ARS, Beltsville, MD. Goat anti-rabbit gamma globulin 
was obtained from Western Chemical Research Corp., Fort Collins, CO. 
Concentrated [-".HIPCF;, and [-H]PGE; with specific activities of 168.0 and 
154.0 Ci/mmol, respectively, were purchased from Dupont New England 
Nuclear, Boston, MA. Standards of PGF;^ and PGE; were obtained from Sigma 
Chemical Co., St. Louis, MO. Scintiverse BD (Fisher Chemical, Fair Lawn, 
NJ) was added to each tube before counting. Sample-containing tubes were 
run in duplicate, one set at beginning of the sample run and the other set 
106  
at Che end. Radioaccivicy was determined as cpm by using a Packard liquid 
scintillation analyzer model 1900 TR (Packard Instrument Co., Downers 
Grove, IL). 
Statistical Analysis 
The hepatic PGF;^ and PGE; concentrations were determined by a 
computer program based on a logit transformation of the standard curve 
(Duddleson et al., 1972). General Linear Models procedure (GLM) was 
performed on feed consumption, body weight, liver to body weight ratio, 
plasma TC level and ALT activity, and hepatic concentrations of PGF;i and 
PGE:, using the Statistical Analysis System (SAS, Release 6.06, Gary, NG). 
Contrasts were done to compare treatment differences. For the analysis of 
percent areas of PGST- and GGT-positive AHF, Student's t-test was performed 
to compare the groups showing lesions. Treatment differences were 
considered significant at P<0.G5. 
RESULTS 
Experiment 1. Feeding Rats 1 mmol Isoflavones with 70 pmol FBi/kg Diet 
There was no significant difference in mean daily feed intake among 
the groups of rats (Table 2). Compared with the control rats, a significant 
reduction in final body weight was found in the rats fed FB-. with and 
wit.hout isoflavones (P<0.05). Feeding isoflavones without FBi. did not 
affect the final body weight as compared with feeding the basal diet (Table 
2) . 
After 4 weeks of feeding, the rats fed isoflavones alone did not 
differ significantly from the rats fed the basal diet in plasma TC 
concentration, ALT activity, and hepatic PGF;, and PGE; production, whereas 
all the measured parameters were significantly greater in the rats fed F3;-
containing diets with and without isoflavones as compared with the control 
rats (?<0.05) (Table 3) . 
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Placental glutathione S-transferase-positive and GGT-positive AHF 
developed in all rats fed 70 pmol FB-/kg diet regardless of dietary 
isoflavone content, but no AHF occurred in the rats fed the basal diet or 
the isoflavones alone (Table 4). 
Experiment 2. Feeding Rats 1 mmol Isoflavones with 18 and 35 pmol FB^/kg 
Diet 
As in Experiment 1, there was no significant difference in mean daily 
feed intake among the groups of rats. Overall mean daily feed intake was 
approximately 11 g (Table 2). Compared with the control rats, all the other 
groups of rats showed an average of 7% lesser final body weight (P<0.05-
0.01). Adding genistein and daidzein at a total isoflavone concentration of 
I mmol/kg diet to either FBi-containing diet (18 or 35 pmol FB;/kg diet) 
did not normalize the body weight (Table 2). With respect to liver weight 
to body weight ratio, there was no significant difference in the ratio 
among all the treatment groups (Table 2) . 
Significant increase by 91% in plasma TC concentration over that cf 
the control rats was found in the animals fed 35 pmol/kg FB, (P<O.Oi) . T.his 
effect of FB: was counteracted by isoflavones, as reflected in that the 
plasma TC concentration of the rats fed FBi (35 pmol/kg diet) + isoflavones 
was significantly less than that of the rats fed FB-, without isoflavones 
(?<0.01). Feeding isoflavones alone or 18 pmol FBi/kg diet did not affect 
plasma TC as compared with feeding the basal diet. There was no significant 
difference in plasma TC between the rats fed 18 pmol/kg FB. and the ones 
fed FB: + isoflavones (Table 3) . 
Similar to the plasma TC concentration, plasma ALT activity of the 
rats fed 35 pmol FB;/kg diet was significantly raised by 86% over that of 
the control rats (P<0.01). Isoflavones at 1 mmol/kg diet normalized plasma 
ALT activity to the control level when added to the diet containing 35 umol 
FB;/kg diet (P<0.01). Neither isoflavones alone nor 18 pmol FB-./kg diet 
affected plasma .^.LT activity. There was no significant difference in plasma 
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ALT activity between feeding 18 pmol/kg FB: with and without isoflavones 
(Table 3). 
Fumonisin Bt at both dietary levels did not significantly affect 
either hepatic PGF:^ or hepatic PGE; concentration over the control, neither 
did isoflavones at 1 mmol/Scg diet. Although adding isoflavones to the diet 
containing 35 pmol/kg FB, lowered hepatic FGF;, concentration by 34%, the 
difference was not significant (P = 0.06) (Table 3). 
Rats fed the diet containing 35 praol FBi/kg developed bot.h PGST- and 
GGT-positive AHF, but adding 1 mmol/kg isoflavones to this FB--contai.ning 
diet significantly diminished the development of PGST- and GGT-positive AKF 
by 75s and 80%, respectively (P<0.05). There were fewer and smaller GGT-
positive AHF in livers of rats fed 1 mmol isoflavones/kg diet with 35 umol 
FB;/kg diet, and the AHF seemed to be less evenly stained than those in 
livers of rats fed 35 umol FB-./kg diet (Figure 1) . There were no AHF 
developed in the rats fed 18 jjmol FB-Vkg diet (Table 4) . 
DISCUSSION 
The ability of a soy isoflavone extract to inhibit FB-.-promoted 
hepatocarcinogenesis was previously investigated in our laboratory. An 
isoflavone extract supplying 1 mmol isoflavones/kg diet was fed with 70 
pmol crudely purified FB, (40% pure)/kg diet to DEN-initiated female rats 
for 4 weeks. The soy isoflavone extract was anticarcinogenic, because it 
blocked development of PGST-positive AHF by over 50%, and decreased plasma 
ALT activity and hepatic PGF:, production which were increased by FB, 
feeding (Hendrich et al., 1997). The effectiveness of a similar isoflavone 
e.xtract to inhibit multistage chemical carcinogenesis was evident in 
another previous study, showing that rat hepatocarcinogenesis promoted by a 
different tumor promoter, phenobarbital, was suppressed by the soy 
isoflavone e.xtract providing 1 mmol isoflavones/kg diet, as indicated by 
t! 
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Che reduced development of PGST- and GGT-positive AHF fLee et al., 1995). 
In both studies, the isoflavone extract was prepared from roasted and 
defatted soy flakes by ethanol and acetone extraction. Those steps of 
preparation could have removed s majority of other proposed 
anticarcinogenic soy constituents such as saponins and Bowman-Birk protease 
inhibitor, so that remaining isoflavones were considered to be responsible 
in large part for the observed anticarcinogenic effect. 
The present studies were designed to prove the proposed anticancer 
ability of isoflavones. Experiment 1, however, showed isoflavones at 1 
mmol/kg diet were unable to suppress hepatocarcinogenesis promoted by 70 
umol/kg FB.., because the changes in plasma TC concentration, plasma ALT 
activity and hepatic prostaglandin production in the rats fed isoflavones -r 
FBi were similar to those in the rats fed FBi alone, and PGST- and GGT-
positive .A.HF developed in all rats fed FB-. regardless of isoflavone content 
(Tables 3 and 4). In contrast. Experiment 2 demonstrated the ability of 
isoflavones at the same dietary level to suppress hepatocarcinogenesis 
promoted by 35 pmol/kg FBi, as evidenced by decreased plasma TC level and 
.ALT activity which were increased by FB;, and significantly reduced 
development of PGST- and GGT-positive AHF in rats fed isoflavones + 35 pmol 
FB:/kg (Tables 3 and 4). Taken together, these results suggested that 
suppression of FBT-promoted rat hepatocarcinogenesis by isoflavones may 
depend upon FB; dose. The hepatocarcinogenesis promoted by 7 0 pmol/kg FB-, 
may be developing more rapidly, so that it could be more resilient to 
suppression by isoflavones. Comparing hepatocarcinogenesis promoted by 
different dietary levels of FB, in the established DEN initiation/FB; 
promotion model, fumonisin Bj. at increasing concentrations caused 
relatively more advanced hepatocarcinogenesis in 4 weeks, as indicated by 
that greater percent areas of PGST- and GGT-positive AHF were found in the 
rats fed 7Q pmol FBi/kg diet vs. 35 umol FB;/kg diet (23% vs. 12% for PGST, 
17% vs. 5% for GGT) (Table 4). A more convincing result was obtained in our 
recent FB- dose-response study showing chat FBi at increasing 
concentrations caused relatively mere advanced hepatocarcinogenesis in 4 
weeks. The severity of FBi.-elicited hepatocarcinogenic effects in rats was 
dose-dependent, as quantified by the mentioned biomarkers associated with 
hepatocarcinogenesis (Lu et al., 1997b). Therefore, isoflavones at 1 
mmol/kg diet suppressed very early stages of hepatocarcinogenesis promoted 
by 35 umol/kg FB-,, but they were ineffective against very rapidly 
developing neoplasia promoted by 70 umol/kg FBi. 
In the present studies, PGST- and GGT-positive AKF developed in rats 
fed 70 umol/kg FBi, and in 92-100% of rats fed 35 umol/kg FB-.. Our FB-. dose-
response study also showed greater percent areas of PGST- and GGT-positive 
.a.HF with increasing FBi concentrations {Lu et al., 1997b). The dose-
dependent increase in the percent areas of PGST- and GGT-positive .A.HF 
suggested that these 2 enzymes were closely associated with FBi-promoted 
hepatocarcinogenesis, and they did serve as early and sensitive biomarkers 
of FB; hepatoto.xicity and hepatocarcinogenicity. Therefore, the 
anticarcinogenic effects of isoflavones on FB-.-promoted 
hepatocarcinogenesis can be readily quantified by the development of PGST-
and GGT-positive AHF. 
The inhibition of AHF formation by isoflavones was accompanied by 
suppression of both plasma TC concentration and plasma ALT activity (Table 
3), biomarkers associated with FBt-promoted hepatocarcinogenesis (Hendrich 
et al., 1993; Lu et al., 1997a). Increased plasma ALT activity generally 
indicates release of the enzyme from damaged hepatocytes with altered 
plasma membrane permeability. Exposure of hepatocytes to hepatotoxicants is 
likely to lead to oxidative stress, which in turn may induce plasma 
membrane dam.age (Halliwell, 1994). Fumonisin Bi as a hepatotoxicant might 
subject hepatocytes to increased lipid peroxidation, based on a reported 
accumulation of polyunsaturated fatty acids in primary hepatocytes treated 
with FB; at 150 and 500 (.imol/L (Gelderblom et al., 1996). Isoflavones as 
antioxidants may alleviate FB..-induced oxidative stress on hepatccyte 
plasma membrane, so that the leakage of ALT from hepatocytes can be reduced 
or prevented. 
The mechanism underlying the stimulatory effect of FB-, on plasma 
cholesterol is unknown. Whether cholesterol-lowering agents can counteract 
the increase in plasma cholesterol stimulated by FBi has not been 
investigated. Therefore, the observed cholesterol-lowering effect of 
isoflavones in Experiment 2 cannot be readily explained. In an experiment 
showing an association of elevated plasma cholesterol with rat 
hepatocarcinogenesis promoted by another tumor promoter (phenobarbital, 500 
mg/kg diet), an isoflavone e.xtract providing approximately 1 mmol 
isoflavones/kg diet was ineffective against hypercholesterolemia [Lee et 
al., 1995). Lack of effect of isoflavones on hypercholesterolemia during 
hepatocarcinogenesis was also demonstrated when an isoflavone e.xtract and 
crudely purified FBi were co-administered to rats for 4 weeks. In that 
study, the isoflavone extract supplied 1 mmol iscflavones/kg diet and the 
concentration of FB, was 70 pmol/kg diet (Hendrich et al., 1997). Perhaps 
isoflavones can be effective against hyperc.holesterolemia during early 
stages of hepatocarcinogenesis promoted by low doses of FB;, but not during 
very rapidly developing neoplasia promoted by high doses of FBi. In other 
words, effect of isoflavones on plasma cholesterol may depend upon doses of 
t.he tumor promoter. This seemingly dose-dependent effect can only be 
e.xplained when the mechanisms of the development of hypercholesterolemia 
associated with hepatoto.xicity and hepatocarcinogenesis is elucidated. 
Mitchell et al. (1978) reported that activity of 3-hydroxy-3-methylglutaryl 
CoA (HMG CoA) reductase, a rate-limiting enzyme of cholesterol 
biosynthesis, was 2-fold greater in primary hepatocellular carcinomas 
induced by feeding 0.04% 2-ac6tyiaminofluorene for 20 weeks than in normal 
livers from rats. Maybe HMG CoA reductase activity can be stimulated during 
FB;-promoted hepatocarcinogenesis as well. Based on elevation of plasma 
LDL, but not HDL or VLDL, and lack of accumulation of cholesterol in livers 
of vervet monkeys fed a low fat diet containing fumonisins, it was proposed 
that the removal of cholesterol from plasma via hepatic LDL receptor could 
be impaired (Fincham et al., 1992). If both mechanisms of 
hypercholesterolemia during FBi hepatocarcinogenesis exist, it would be 
more difficult for isoflavones to counteract this effect. 
Hepatic prostaglandin production was only significantly stimulated in 
rats fed FB-. at 70 pmol, but not 35 ^imol/kg diet. In contrast, development 
of PGST- and GGT-positive AHF, plasma ALT activity and plasma cholesterol 
concentration were increased at both FB; concentrations. This suggested 
that hepatic prostaglandin production may not be as a sensitive biomarker 
as t.he others. 
Experiment 1 showed that feeding isoflavones with FB- did not 
suppress hepatic prostaglandin synthesis which was increased by 70 umol 
FB-_/kg diet, and Experiment 2 demonstrated that effect of feeding 
isoflavones on hepatic prostaglandin concentrations was marginal compared 
with feeding FB-. at 35 umol/kg diet (P=0.06) . Our previous study, however, 
showed a lowering effect of the isoflavone extract on hepatic PGF:, 
concentration (Hendrich et al., 1997). These results suggested that in 
addition to genistein and daidzein, other components in the isoflavone 
extract might also contribute to the prostaglandin-suppressive effect. 
In conclusion, isoflavones suppressed rat hepatocarcinogenesis 
promoted by 35 umol FBi/kg diet. They were ineffective against very rapidly 
developing neoplasia promoted by 70 pmol FBi/kg diet. Suppression of FB-.-
promoted hepatocarcinogenesis in rats depended upon FB^ dose. 
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Table 1. Concentrations of Genistein (G) , Daidzein (D) and Fumonisin Bi 
(FBi) in Experimental Diets* 
Genistein Daidzein Fumonisin B-. 
Experiment 1 
Diets 
Basal 0 0 0 
G 1 .nmol/kg 0 0 
D 0 1 mmol/kg 0 
G + D 0. ,5 mmol/kg 0, .5 mmol/kg 0 
F3i-70 0 0 70 umol/kg 
G + FB--7 0 1 mmol/kg 0 70 umol/kg 
D FB;-70 0 1 mmol/kg 70 umol/kg 
G ^ D + FB, -70 0. 5 mmol/kg 0. 5 mmol/kg 70 umol/kg 
Experiment 2 
Diets 
Basal 0 0 0 
G - D 0. 5 mmol/kg 0 . ,5 mmol/kg 0 
FB,-35 0 0 35 pmol/kg 
FB:-18 0 0 18 umol/kg 
G - D + FB, -35 0. 5 mmol/kg 0 . 5 mmol/kg 35 pmol/kg 
G  ^D + FB,. -18 0. 5 mmol/kg 0. 5 mmol/kg 18 umol/kg 
'In the experimental diets, FB--70 = 70 umol FBT/kg diet, FB;-35 = 35 pmol 
FB-./kg diet, and FB:-18 = 18 pmol FB,/kg diet. 
Table 2. Average Daily Feed IntsJce, Final Body Weight and Liver Weight to 
Body Weight Ratio (LW:BW Ratio) of Rats Initiated with Diethylnitrosamine 
and Promoted with Fijmonisin Bx (FBi) * 
Feed Intake Body Weight LW:BW Ratio 
(g/d) (g) (xlO-) 
Experiment 1 
Diets 
Basal 10 ± 2 112 + 11^ 
10 1 118 + 10^ 
n 10 + 113 ± 12'i 
G ^ D 10 ± 1 115 ± 10^ 
FB-.-70 9 + o Z. 106 + 8"= 
G + FB;-70 9 + 2 106 + 12" 
D - F3..-70 9 2 102 ± 12"= 
G - D -r FB;-70 10 X 105 11= 
Experiment 2 
Diets 
Basal 10 1 119 + ga 4, . 4 •f 0.3 
G D 11 ± 2 111 •f 1° 4 , . 3 ± 0.3 
FB-.-35 10 2 110 •f 7" 4 ,  5 ± 0.5 
FBi-18 10 2 112 + 10° 4 . 2 ± 0.2 
G + D + FB--35 12 ± 2 110 + 6" 4 , .3 + 0.3 
G + D + FB;-1S 10 ± 2 113 + 8° 4 . .4 + 0.3 
'In the experimental diets, G = Genistein, D = Daidzein, FBt-70 = 70 umol 
FB-./kg diet, FBi-35 = 35 umol FBi./kg diet, and FBi-18 = 18 pmol FB:/kg diet. 
Values are given as group means ± standard deviations, n=12. Groups with 
different letters were significantly different (P<0.05-0.01). 
Table 3. Plasma Total Cholesterol (TC) Concentration, Alauxine 
Aminotransferase (ALT) Activity, and Hepatic Prostaglandin (PG) and E2 
Levels in Rats Initiated with Diethylnitrosamine and Promoted with 
Fumonisin Bx (FBi) * 
Plasma TC Plasma ALT Hepatic PGF:, Hepatic PGE; 
(mg/dL) (u/L) (ng/g) (ng/g) 
Experiment 1 
Diets 
Basal 85 -f 36" 33  ga  10  3" 3  ± 1 ^  
G 89 32a  31  •T 8^ 11  
-
5" 4  + ' 
D 92 + 24^ 32  10" 3 - f - 4"  3  1" 
G + D 88 ± 26" 29  ± 10" 9  r 5" 4  t 2" 
FBi-70  143  53^= 50  + 16°  19  + 9°  8  + 4°  
G + FBi-7  0  146  ± 62°  47  + 15°  18  -f 9°  7 3=: 
D + FB:-7  0  141  4. 57'=  49  + 13^= 22  + 9°  3 3°  
G + D FBi  -70  149  + 4 3°  47  12°  20  ± 7°  9 + 4°  
Experiment 2 
Diets 
Basal 89 15  28  4  59  + 34 50  4- 16 
G + D 82 •f- 10  25  ± 3 58  ± 32 49  ± 26 
FB,-35  170  4.  52 '=  52  + 25- '  85  + 50 60  4- 23 
FB:-18  103  28  27  ± 6 61  + 37 56  ± 26 
G -i- D + FBi  -35  134  + 4 3°® 30  + 6= 56  -f 31 53  ± 21 
G +  D +  FBi  -18  8  5  4.  11  29  6  59  + 26 55  ± 15 
'In the experimental diets, G = Genistein, D = Daidzein, FBi-70 = 70 pmol 
FB-Vkg diet, FB^-SS = 35 umol FBi./kg diet, and FB-.-lS = 18 ^imol FBi/kg diet. 
Values are given as group means ± standard deviations, n=12. Groups with 
different letters (a, b) were significantly different in Experiment 1 
(P<0.05). 
"Significantly different from the control group in Experiment 2 (P<0.01). 
'Significantly different from the FBi-35 group in Experiment 2 (P<0.01;. 
'Significantly different from the control group in Experiment 2 (P<0.01;. 
Table 4. Percexx't Areas of Placental Glutathione S-Trans£erase-Positive 
(PGST*) and Ganunf>-Glutamyltransferase-Positive (GGT^) Altered Hepatic Foci 
(AHF) in Rats Initiated with Diethylnitrosamine and Promoted with Fumonisin 
Bi (FBi)* 
i of Rats ^ Area of % of Rats % Area of 
Showing PGST* PGST' AHF Showing GGT* GGT* AHF 
AHF AHF 
Experiment 1 
Diets 
Basal 0 0 0 0 
0 0 0 0 
D 0 0 0 0 
G - D 0 0 0 0 
FB:-70 100 23 ± 19 100 18 ± 17 
G FB-.-70 100 21 ± 18 100 16 + 16 
D + FB:-70 100 23 + 15 100 19 + 17 
G + D r FBi-7 0 100 23 + 19 100 15 ± 13 
Experiment 2 
Diets 
Basal 0 0 0 0 
G + D 0 0 0 0 
FB:-35 92 12 13 92 5 + 5 
FB,-13 0 0 0 0 
G + D + FBi-35 92 3 + 4^ 75 1 + 2a 
G +• D F3i-I8 0 0 0 0 
"In the experimental diets, G = Genistein, D = Daidzein, FB;-70 = 70 umol 
FB-Vkg diet, FBi-35 = 35 umol FB,./kg diet, and FB-.-lS = 18 umol FBVkg diet. 
Values are given as group means ± standard deviations, n=12. 
'Significantly different from the FB-.-35 group {P<0.05;. 
Figure 1. Fewer aind smaller gamma-glutamyltransferase-positive altered 
hepatic £oci developed in livers o£ rats fed 1 mmol isoflavones with 35 
(jmol FBi/kg diet (A) , and the AHF seemed to be less evenly stained than 
those in livers of rats fed 35 |imol FBi/kg diet (B) . 
< 
GEaJERAL CONCLUSIONS 
Placental glutathione S-transferase- and GGT-positive AHF were 
closely associated with FB,-promoted hepatocarcinogenesis, and they did 
serve as early and sensitive biomarkers of hepatotoxicity and 
hepatocarcinogenicity. Development of PGST- and GGT-positive AHF was also 
accompanied by increased plasma ALT activity and cholesterol concentration 
at both 50 ppm (70 pmol/kg diet) and 25 ppm (35 lomol/kg diet) FB-.. Hepatic 
prostaglandin production was only significantly stimulated in rats fed FB-
at 70 pmol but not 35 pmol/kg diet. Therefore hepatic PG synthesis may not 
be as a sensitive biomarker as are PGST- and GGT-positive AHF, plasma ALT 
activity, and TC concentration to quantify FBi hepatotoxicity and 
hepatocarcinogenicity. 
Feeding as low as 25 ppm FB- for 4 weeks induced hepatocarcinogenesis 
in DEM-initiated rats. The short-term cancer-promoting threshold dose cf 
FS: was probably >12.5 ppm (18 ^mol/kg diet) but <25 ppm. 
The amine group of FBt was critical to FB^ hepatoto.xicity and 
hepatocarcinogenicity. Subjecting FB- to nonenzymatic browning conditions 
with fructose blocked the amine group and thus eliminated FBi 
hepatocoxicity and hepatocarcinogenicity. 
Isoflavones as antioxidants may alleviate FBi-induced oxidative 
stress on hepatocyte plasma membrane, so that the leakage of .ALT from 
hepatocytes can be reduced or prevented. Effect of isoflavones on 
hypercholesterolemia associated with FBi-promoted hepatocarcinogenesis may 
depend upon doses of the tumor promoter. 
Isoflavones suppressed rat hepatocarcinogenesis promoted by 35 umol 
F3;/kg diet, but they were ineffective against very rapidly developing 
neoplasia promoted by 70 umol FBi./kg diet. Suppression of FBi-promoted 
hepatocarcinogenesis in rats depended upon FB-. dose. 
Future studies are greatly needed to understand the mechanisms of FB-
toxicity and carcinogenicity, to determine whether there is a causative 
relationship between FBi and human esophageal cancer, to establish 
tolerance levels for FBt in corn-based human foods and animal feeds, to 
identify the structure of the putative FBi-fructose conjugate, to 
investigate its stability, possible processing occurrence, bioavailability 
and toxicity in other organs, and to elucidate the mechanisms of the 
observed anticarcinogenic effects of isoflavones. 
These findings should help establish an action level for FB-., develop 
effective FB-. detoxification through processing of corn-based food, and 
further explore anticarcinogenic ability of isoflavones. 
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